Blog

Kyalami FoM 2022: Mercedes-Benz EQ range fully detailed – The Citizen

Motoring
Charl Bosch
Following the initial announcement in January this year, Mercedes-Benz officially announced its line-up of all-electric EQ models, as well as pricing, at the Kyalami Festival of Motoring this week.
The three-pointed star’s competition for BMW’s i and Audi’s e-tron brands, the initial range will comprise four models headed by the EQS, with the smaller EQE tipped to follow more than likely towards the end of the year or sometime in 2023.
Starting the line-up off is the EQA, which uses the GLA as a base instead of riding on a dedicated electric focused platform like the EQS.
As with the global model, South Africa will be privy to a single derivative, the EQA 250 that produces 140kW/375Nm thanks a 66.5-kWh battery driving a front axle mounted electric motor.
ALSO READ: Mercedes-Benz flips the switch on EQ in South Africa
Able to accelerate from 0-100 km/h in 8.6 seconds and reach a limited top speed of 160 km/h, the EQA has a claimed range of 429 km and according to Mercedes-Benz, can be charged-up from 0-100% in six hours using an 11 kW charger or wallbox.
Plugged-in to a faster 100 kW charging station though reduces the claimed waiting time from 0-80% to 30 minutes.
Sitting above the EQA is the EQB, which also uses a conventional internal combustion powered model as its foundation, in the case, the GLB relaunched in South Africa earlier this year.
Like its sibling, the EQB differs mostly cosmetically and of course underneath the bonnet, which hides a smaller 66-kWh battery that produces 215kW/520Nm in the 350 variant.
Unlike the EQA, the EQB features a second electric motor on the rear axles resulting in it receiving not only the 4Matic moniker, but also better performance with the 0-100 km/h sprint taking 6.2 seconds. Top speed is still limited to 160 km/h.
Despite its greater outputs and improved performance, the inclusion of the second motor translates to a claimed range of 423 km with the waiting time being identical to that of the EQA.
The ability to be charged from a 150 kW supercharger however means a waiting time of 15 minute from 0-100%.
Whereas sales of the EQA are now open, those of the EQB only commence in October.
The initiator of the EQC brand in 2019, the EQC finally becomes available following an aborded planned debut in 2020 as a result of the onset of Covid-19.
Now the oldest EQ model, the EQC, like its lesser siblings, will be only sold in a single derivative, the 400 that produces 300kW/760Nm thanks to a 80-kWh battery driving front and rear axle electric motors.
Immediately all-wheel-drive as a result, the EQC 400 will accelerate from 0-100 km/h in 5.1 seconds and hit a top speed of 160 km/h. The claimed range is 450 km/h.
Arguably the biggest EQ showcase is the EQS, which premiers not only as Benz’s flagship EV in South Africa, but also the electric equivalent of the S-Class that touched down in May this year.
Billed as the model that “redefines the luxury-sedan segment”, the EQS will have a choice of two models, the conventional 450+ and performance AMG 53, with latter getting the dramatic 64-inch Hyperscreen display as standard.
Up front, motivation comes courtesy of a 107.8-kWh battery driving a rear mounted electric motor on the 450+ and a pair on the AMG 53 that warrants the all-wheel-drive 4Matic+ designation.
As for grunt, the 450+ produces 245kW/568Nm which translates to a top speed of 210 km/h and 0-100 km/h in 6.2 seconds. The claimed range is also the most of any EQ model at 782 km according to the three-pointed star.
As the first all-electric AMG model, the battery and motors in the AMG 53 have been turned-up to produce 484 kW of power and 950 Nm of torque.
As part of the optional AMG Driver’s Package however, an overboost function raises the outputs to 560kW/1 020Nm which puts the EQS AMG 53 on par with the Audi RS e-tron GT and Porsche Taycan Turbo for South Africa’s most powerful electric vehicle.
Faster from 0-100 km/h than the 450+ with a time of 3.8 seconds, the AMG 53 is also 10 km/h better off at 220 km/h, but loses out on range with Mercedes-Benz claiming 586 km between trips to the plug.
2022 The Citizen. All Rights Reserved.

source

OBS Studio 28.0 is a Massive Upgrade With Qt6, HDR Support; Also Works on Apple Silicon – It's FOSS News

OBS Studio 28.0 gets a visual refresh, and gears up for modern use-cases with new tech support.
One of the most popular pieces of open-source software, OBS Studio, gets a major upgrade.
It is one of the best screen recorders on Linux, and for that matter, pretty much every other desktop platforms too (Windows/macOS). This release brings a boatload of new features, which build upon the numerous previous features as well.
Let’s take a look at what’s new!
The last release that we covered, OBS 27.2, brought official Flatpak support as well as a plethora of UI improvements.
With version 28.0, we are getting some of the key highlights that include:
Before you get to try it out, let me briefly discuss some enhancements.
As OBS Studio becomes ever more popular, it was time to support more modern use cases. One such case is the use of HDR to allow for significantly greater realism without “clipping” the screen. This means that whites can be whiter, and blacks can be blacker, without losing the accuracy of colors in between.
Speaking of colors, OBS Studio 28.0 also introduces 10-bit color support. In essence, this means that streams captured using OBS can support as many as 1 billion colors, compared to the measly 16 million offered by 8-bit color. The result is an almost complete removal of blocks of color in dark settings, as well as smoother gradients without having to resort to dithering.
Although not of particular relevance to Linux users, this release is the first with native Apple Silicon support. We’ve already seen native ARM support for other platforms, (notably Linux and the Raspberry Pi), and it is great to see this support extend to Apple’s ARM platform.
However, it should be noted that not all plugins will work out of the box on these builds, as many depend on some x86-only components. Therefore, using the x86 version may still be better, at least until all the plugins you use get updated.
Qt, the software used to make the graphical components of OBS, has had a major upgrade within this version. Previously, OBS Studio used Qt5, the same software KDE Plasma is built using.
OBS Studio 28.0 finally brings Qt6 support, which has a huge number of benefits for all platforms. Firstly, it means that OBS Studio can use Vulkan or Metal instead of the outdated OpenGL API. For users on high DPI monitors, OBS Studio should also now scale correctly.
Unfortunately, this change also means that some older platforms can no longer be supported. So, if you are using Ubuntu 18.04 or older, Windows 7 or 8, or a 32-bit OS, it may not work.
One can expect a visual makeover with the UI framework update. And, the new default theme gives you that. It looks pretty clean compared to its older version.
Alongside those previously mentioned, OBS Studio brings a couple of other, smaller changes. These include:
For more details, you can refer to the official release notes.

The best way to get the latest version is to install the Flatpak package via Flathub. You can also get it using the Steam client on any platform.
For other platforms and options, you can head to its GitHub releases section to download packages.

Overall, this release has brought a huge number of exciting new changes, and I’m curious to see how they affect peoples workflows.
Unfortunately, if you are on KDE, the main UI may look somewhat broken, due to an incompatibility with KDE’s breeze theme. However, for everyone else, I wouldn’t expect any major bugs.
Please share your thoughts on this release in the comments down below!

source

LIVE Transfer Talk: Man United's Cristiano Ronaldo to make Fenerbahce move? – ESPN

Erik ten Hag confirms Cristiano Ronaldo is in his plans for Man United ahead of the summer transfer window closing. (0:48)
The summer transfer window is closed for the major leagues in Europe. However, with an eye on January, there’s plenty of gossip swirling about who’s moving where. Transfer Talk brings you all the latest buzz on rumours, comings, goings and, of course, done deals!
The Cristiano Ronaldo saga took a late deadline day twist on Thursday with reports in Turkey indicating that the 37-year-old Manchester United striker has agreed in principle to join Fenerbahce.
Ajansspor says that only the final details are required before the move can become official, after the Portugal international reached an agreement with Fenerbahce president Ali Koc.
It is reported that Ronaldo met with manager Jorge Jesus, who was able to persuade his compatriot to make the switch to the Super Lig, and with the transfer window now closed across Europe’s top leagues, the Yellow Canaries are optimistic of landing him ahead of other suitors.
The transfer market remains open until Sept. 8 in Turkey, giving Fenerbahce until then to reach an agreement over a fee with United, who have won their last three Premier League games in which Erik ten Hag has named Ronaldo among the substitutes.
Fenerbahce have also signed Chelsea striker Michy Batshuayi, after his deal collapsed with Nottingham Forest late in the window.
– Stream on ESPN+: LaLiga, Bundesliga, MLS, more (U.S.)
22.00 BST: Alright, that’s it for another busy day of rumours, conjecture and transfer chatter. Check ESPN FC later for the next installment!
21.30 BST: Talks over a deal involving Caglar Soyuncu and Fenerbahce have started, according to Ajansspor.
Leicester City could be prepared to part ways with the 26-year-old centre-back, who is now in the final 12 months of his contract at the King Power Stadium. The Super Lig side are reported to see him as a potential reinforcement after key starter Serdar Aziz picked up an injury.
21.00 BST: Paris Saint-Germain feminine are continuing to dismiss approaches from Chelsea for Grace Geyoro, reports Le Parisien.
The 25-year-old midfielder has been a high priority target for Chelsea manager Emma Hayes this summer, but there are now just days to complete the deal with the Women’s Super League transfer market set to close on Sept 8.
It is understood that she is keen to make the switch to Kingsmeadow, having spoken of her desire to go in search of a new challenge, but PSG are doing all they can to keep hold of the France international who has earned 56 caps for her country.
20.30 BST: Wolves are open to adding another centre-back if they can find a target who would add experience to Bruno Lage’s side.
Speaking on free agent Jason Denayer, as quoted by Fabrizio Romano, the Wolves manager said: “Let’s see what happens in the next days, I know Denayer very well. We’re happy with our centre-backs, but there’s a gap and if we have a chance to bring in one experienced player, it would be better.”
Belgium international Denayer, 27, has been a free agent since his contract expired with Lyon in the summer.
20.00 BST: Premier League sides were keen to land Sander Berge before the transfer window closed, but couldn’t match Sheffield United’s valuation, manager Paul Heckingbottom reveals.
Speaking to the Yorkshire Post, he said: “There were no further offers. There were lots of conversations, not just Brugge, one real good Premier League club were discussing Sander and his name, but no one could get to the number.”
Liverpool are understood to be one of the clubs who were interested in the 24-year-old midfielder’s signature.
19.30 BST: Bayern Munich have no plans to part ways with Jamal Musiala any time soon, says Sky Sports Germany.
It is reported that sporting director Hasan Salihamidzic has made it clear that no proposals will be considered for the talented 19-year-old winger, who has scored three goals from the opening four Bundesliga matches.
19.00 BST: Leeds United considered a late approach to sign Leicester City striker Kelechi Iheanacho, understands the Athletic.
Jesse Marsch’s side were busy on Thursday as they found themselves miss out on a move for Bamba Dieng, and it is reported that they were keen on Iheanacho if they failed to acquire Italy international Wilfried Gnonto. Iheanacho, 25, has been named among the substitutes for all of the Foxes’ Premier League games so far this season.
18.44 BST: Up next, there’s a new arrival at Barcelona, finally…
Look who’s in town 👋💥 pic.twitter.com/2uTHAWsnzP
(Yep, that’s former Chelsea defender Marcos Alonso alright…)
18.30 BST: Cody Gakpo is set to be handed a new contract with PSV Eindhoven, writes Eindhovens Dagblad.
The 23-year-old midfielder was the subject of heavy Premier League interest throughout the transfer window, but the Eredivisie club were only willing to part ways with him for the right valuation. It is reported that he will soon sign an improved contract as a reward for his loyalty to the club.
18.00 BST: Mauro Icardi will take time to discuss with his family before going ahead with a potential move to Galatasaray, according to Calciomercato.
The 29-year-old Paris Saint-Germain striker has been strongly linked with the Super Lig club in recent weeks, having found himself cast out of new PSG manager Christophe Galtier’s plans. While he is open to making the move away from the Parc des Princes, it is understood that he wants to ensure that his family would be willing to support the decision.
17.30 BST: Liverpool will have the opportunity to acquire Arthur Melo on a permanent basis, Juventus revealed during their official announcement.
The 26-year-old midfielder completed a loan move to Jurgen Klopp’s side on deadline day, but while initial reports suggested the transfer would be a straight loan deal, the Bianconeri note in their farewell message that a €37.5million permanent option clause has been included.
17.00 BST: There remains uncertainty over whether Josh Onomah will be able to complete his move from Fulham to West Bromwich Albion, reports the Telegraph’s Mike McGrath.
The Baggies are understood to have received some required paperwork late which affected their ability to meet the deadline in the deal for the 25-year-old midfielder. The player is reported to be waiting at a hotel to see whether the move will be allowed to go through.
16.00 BST: Barcelona landed Arsenal defender Hector Bellerin on a free transfer.
Sam Marsden explains why Hector Bellerin is such a good fit for Barcelona.
14.40 BST: Pep Guardiola says Manchester City were forced into the transfer market to sign Manuel Akanji over fears about Aymeric Laporte’s fitness.
City completed the €17.5m signing of Akanji from Borussia Dortmund on deadline day. And Guardiola says the decision was partly down to the availability of Laporte, who has not played this season after undergoing knee surgery in the summer.
“We have four incredible centre-backs before but sometimes we’ve had it tough with injuries,” Guardiola told a news conference on Friday. “Some are getting better but a month or month and a half [for Laporte] and Nathan [Ake] could not play [the last two games].
“So we’ve just had two centre-backs. We had an opportunity to bring him [Akanji], one year left in Dortmund, a lot of experience, he’s perfect for what we need and we’re very pleased to have him here as competition.”
14.16 BST: Mikel Arteta has admitted his frustration at Arsenal’s failure to sign a midfielder on deadline day after confirming Mohamed Elneny will be sidelined for several months with a hamstring injury.
Sources told ESPN that the Gunners had three bids rejected for Aston Villa’s Douglas Luiz on Thursday — the last of which was worth £25m — as they tried to bolster their midfield options in the wake of setbacks for Elneny and Thomas Partey.
Asked about his disappointment at missing out on Luiz, Arteta told a news conference: “Listen, we had a lot of things still to do in the squad. You see the amount of departures comparing to the players that we have recruited.
“The club has done a phenomenal job and put everything on the table to try to bring the players and the profiles we wanted. We did business pretty early but unfortunately in the last 72 hours, Thomas got injured in the same place he got injured last time and then Mo has a long-term injury and we had to react in the market. We tried but at the end of the day, we have to bring the player that we feel is the right player for the team and as well for the club and we didn’t manage to do that.”
Villa were adamant they would not let Luiz depart, with Danilo at Palmeiras one of several other players under consideration. However, Arteta suggested the club were determined not to overpay or panic late in the window after past mistakes.
“We have our limitations,” he said. “Time was a big limitation with what happens in the last 72 hours in our midfield and we tried to act but we didn’t find the right player.
“We have learned a lot from that and the players we have to get out, we only have to bring top talent, top quality people through that door and be very disciplined. In those moments, you can make huge mistakes that can cost the club and the team a lot, not in the near future but maybe a little bit ahead and we want to avoid that as much as possible.”
13.55 BST: Premier League clubs have broken their transfer spending record for a season in the summer window alone, spending £1.9 billion ($2.2bn) during the period, according to analysis from finance company Deloitte.
The summer transfer window, which closed on Thursday, beat the previous record of £1.86bn ($2.5bn) spent in a whole season, which was set in 2017-18.
It also beat the previous summer spending record of £1.4bn ($1.6bn) set in 2017.
Several other records were broken in the same window, including Premier League clubs spending more than Spain’s LaLiga, Italy’s Serie A and the German Bundesliga combined.
13.34 BST: Former Tottenham defender Jan Vertonghen has left Benfica and joined Anderlecht on a two-year deal.
Vertonghen, 35, has 139 caps for Belgium but has never competed in the Belgian league, having signed for Ajax Amsterdam in the Netherlands as a teenager and then playing over 300 games at Tottenham before spending the last two season at Benfica in Portugal.
The move allows the central defender to continue to play regularly and keep up his place in the Belgium national team, who are headed to the World Cup in Qatar later this year.
13.00 BST: ICYMI — news of two USMNT stars from Thursday.
– AC Milan have completed the signing of United States international Sergino Dest on a season-long loan from Barcelona. The Serie A champions have an option to make the deal permanent next summer for €20m.
ESPN reported earlier this summer that Barca coach Xavi Hernandez had told Dest he was no longer part of his plans. Dest, 21, initially said he wanted to stay at Camp Nou but changed his mind after being left out of the squad for the opening three games of the season. The defender is set to feature for U.S. at the World Cup, which begins in November, and he decided the offer from Milan, who will play in the Champions League this season, was too good to turn down.
– Christian Pulisic will stay at Chelsea at least until January after the summer transfer window closed without a move materializing.
Pulisic has yet to start any of Chelsea’s first five games of the Premier League season, appearing for a total of 95 minutes off the substitutes’ bench. The 23-year-old has been linked with a move away from Stamford Bridge this summer in order to find regular playing time ahead of the 2022 World Cup, which starts in November.
ESPN reported last month that Pulisic held talks with Chelsea over his future. One source with knowledge of the discussions told ESPN that Pulisic was informed he would be used primarily as an impact player, but with every chance he could break into the first team.
11.42 BST: Fenerbache have signed Chelsea striker Michy Batshuayi after his deadline day move to Nottingham Forest collapsed.
Batshuayi, 28, scored 14 goals in 42 games on loan at Besiktas last season but has returned to Stamford Bridge and has struggled for game time.
He is now set to head back to the Turkish league.
11.20 BST: Man United’s big-money moves for Antony, Casemiro revealed manager Erik ten Hag’s growing authority. ESPN’s Rob Dawson goes inside the club’s summer transfer dealings.
Ten Hag has got almost everything he wanted this summer, but it has also been a window (also dominated by the saga of Cristiano Ronaldo ultimately staying put) that has, at times, appeared haphazard and reflected what has been a struggle for authority behind the scenes.
In the end, United have signed more players and spent more money than they originally planned, and much of that has been down to Ten Hag’s own persistence. Sources have told ESPN that, more than once, the club were keen to walk away from negotiations with Ajax regarding Antony. The Brazil winger was a player identified as a possible target as early as March, but Ajax’s valuation of more than €80m made the deal problematic from the start.
It was agreed that other attacking options would be considered with Chelsea’s Christian Pulisic and Borussia Monchengladbach’s Marcus Thuram put forward by the recruitment department, and PSV’s Cody Gakpo, who shares an agency with Ten Hag, proposed by the manager.
Deals for each were discussed internally, but Ten Hag insisted Antony was still the best fit and implored the club to go back to the negotiating table. By that point Ajax felt emboldened to ask for more — in part to cover solidarity payments owed to Antony’s former clubs — having already raised more than €116m in outgoings. United saw an €80m bid rejected and when an improved €90m offer was also turned down, recruitment chiefs wanted to end negotiations.
It was only after Ten Hag stepped in again that an agreement was reached for an initial €95m with another €5m in add-ons to make Antony the second-most-expensive signing in the club’s history behind Paul Pogba when he arrived from Juventus in 2016 for €105m.
11.00 BST: Chelsea signed Pierre-Emerick Aubameyang for €12m, but should they have?
James Olley questions whether Pierre-Emerick Aubameyang fits Thomas Tuchel’s style of pressing the ball from the front.
09.45 BST: Nottingham Forest made their 21st signing of the summer on Thursday, breaking the English record for the most arrivals in one transfer window.
Forest, who secured promotion to the Premier League last season, completed deals for defenders Loic Bade, from Rennes, and Willy Boly, from Wolves, as well as winger Josh Bowler from Blackpool on a hectic final day of the transfer window. Bowler was subsequently loaned to Greek side Olympiakos for the remainder of the season.
The previous record for most signings by an English club in one transfer window was Crystal Palace’s 17 in the summer of 2013, according to Transfermarkt.
Forest’s total could yet increase further with reports that they had agreed a deal to sign free agent Serge Aurier.
09.32 BST: Real Betis midfielder William Carvalho has signed a new contract until June 2024.
I’ll start.#WilliamExtension pic.twitter.com/g58ezbMawW
09.11 BST: Arsenal‘s deadline day attempts to sign Douglas Luiz saw Aston Villa reject a third bid for the midfielder in the region of £25m, sources have told ESPN’s James Olley.
With just over an hour of the window remaining, Arsenal had a third offer for the 24-year-old turned down after seeing previous bids of £20m and £23m rejected earlier on Thursday.
Villa were adamant throughout negotiations that Luiz would not leave, despite the Brazil international having just one year remaining on his contract. Sources have told ESPN that Villa have not given up convincing Luiz to sign a new deal.
09.00 BST: Chelsea announced last night that left-back Marcos Alonso‘s contract was terminated by mutual consent.
The Spain international, who spent six years with Chelsea, is set to join Barcelona and is set to be presented today on a free transfer.
Julien Laurens and Gab Marcotti discuss Neymar’s future amid reports that PSG want him to leave.
– PSG offered Manchester City the chance to sign Neymar at the end of the window, says Marca. Neymar, the world’s most expensive player at €222m, is under the spotlight as his relationship with striker Kylian Mbappe has suffered in recent games. However, concerned at the impact Neymar would have on the City dressing room, Pep Guardiola said no.
– Mundo Deportivo claims that Real Betis are interested in signing former Man United forward Juan Mata. The 34-year-old is a free agent after leaving United this summer and has also been linked with a move to his old club Valencia.
– Chelsea made a €50m bid to sign Ajax and Mexico midfielder Edson Alvarez, sources have told ESPN, but De Telegraaf claims the Dutch club did not allow him to leave as they felt they had lost too many players this summer. The 24-year-old refused to train in order to push through a move but was told in a meeting with Ajax technical manager Gerry Hamstra and ex-striker Klaas-Jan Huntelaar that he would not be allowed to move.
– Calciomercato says that AC Milan were ready to move for Arsenal forward Gabriel Martinelli if Chelsea landed Rafael Leao. The Blues reportedly made a bid of €80m plus players to sign the Portugal forward, but Milan rejected it.

source

VILLE VALO Releases New Single "Echolocate Your Love" From Upcoming Album 'Neon Noir' – Icon Vs. Icon

The Source For All Things Pop Culture
Finnish Love Metal pioneer Ville Valo (VV) has released “Echolocate Your Love,” the second single from his forthcoming debut solo album ‘Neon Noir’. The album will arrive in early 2023.
The elegiac goth-optimism of “Echolocate Your Love” gives a fuller picture of the wrought elegance to come. Watch the video HERE.
“It’s a sonic step-by-step guide on how to survive, and perhaps even enjoy, the realm of VV with its abundance of things that go bump in the night,” says Valo. “It’s a teary mascara marathon between Robert Smith and Ozzy, with a dash of hope.”

You can watch the previously released video for “Loveletting” HERE.
Further details about ‘Neon Noir’ will be released in due course. In the meantime, VV’s headline tour, taking place next year across Europe, the UK and North America – has already sold-out across a number of cities.
Get your tickets HERE to avoid disappointment.
NORTH AMERICAN 2023 TOUR DATES:
3/31—Philadelphia, PA—Theater of Living Arts
4/1—Philadelphia, PA—Theatre of Living Arts*
4/2—Boston, MA—Big Night Live
4/4—Pittsburgh, PA—Roxian Theatre
4/5—Cleveland, OH—House of Blues
4/6—Detroit, MI—St Andrews Hall
4/8—Cincinnati, OH—Bogarts
4/9—Chicago, IL—House of Blues*
4/10—Chicago, IL—House of Blues
4/11—Minneapolis, MN—Varsity Theater
4/13—Denver, CO—Summit
4/14—Salt Lake City, UT—The Depot
4/16—Sacramento, CA—Ace of Spades
4/17—San Francisco, CA—The Fillmore
4/18—Los Angeles, CA—The Belasco*
4/19—Los Angeles, CA—The Belasco
4/21—Las Vegas, NV—House of Blues
4/22—San Diego, CA—House of Blues
4/23—Phoenix, AZ—The Van Buren
4/25—Dallas, TX—House of Blues
4/26—San Antonio, TX—Aztec Theater
4/27—Houston, TX—House of Blues
4/28—New Orleans, LA—House of Blues
4/30—Orlando, FL—House of Blues
5/1—Ft Lauderdale, FL—Revolution
5/3—Atlanta, GA—Buckhead Theatre
5/4—Nashville, TN—Brooklyn Bowl
5/5—Charlotte, NC—Underground
5/7—Silver Spring, MD—The Fillmore
5/8—New York, NY—Irving Plaza
*SOLD OUT
ABOUT VILLE VALO / VV:
In the annals of 21st century alternative rock history, there are few artists who cast a longer or more peculiar shadow than Finnish Love Metal pioneer Ville Valo. After all, his band HIM was easily among the most iconic and idiosyncratic groups of the millennium.
Zealously revered, gleefully reviled but impossible to ignore, their music left an indelible mark on a worldwide legion of fans. The scarlet letters stood for “His Infernal Majesty.” Their founder stood for something delightedly out of step with the status quo.
“We only hoped to temporarily redirect hard rock’s blood flow from the nether regions towards the heart,” reminisces Valo, the singer, songwriter, and primus motor of HIM. Judging by the monolithic presence of the Heartagram in any account of music this side of the millennium, it’s apparent that he succeeded.
Inspired by everyone from Poe to Bukowski and tinged by a penchant for perfumed Sabbathian gloom, Valo’s creative lovechild would produce eight era-defining studio releases and over 10 million record sales, including a Grammy nomination, countless magazine covers, critical acclaim, and the veneration of a generation. Thus, it came as no surprise that the news of a farewell tour in 2017 was greeted with shock and disbelief among devotees and caused endless speculation as to what or who was to take up the velvet mantle.
“As fun as the funeral rites for HIM were, it took me more than a few moons to lick my wounds in the shadow of the Heartagram and come up with an excuse to strum and hum again. Eventually, I decided to put a leash on my beloved black dog and we started howling together instead of barking at each other. That’s how “Loveletting” was born.”
“Loveletting”, the first single off VV’s debut album ‘Neon Noir’, out in early 2023, suggests this new infernal mix of light and shade is nothing short of a landmark release from one of modern music’s most distinctive and intriguing voices. It belongs to the same forlorn world of woe and whimsy once conceived and governed by Valo in HIM, but with the nuanced notes of a fine aged Cabernet.
“Artistically speaking, the main difference between HIM and VV is the extra line in the Heartagram, but what an exquisite line it is! It’s the Mamas and the Papas dressed up as Metallica on their way to a Halloween bash at the Studio 54, and now who wouldn’t want to witness that?”
 
Jason Price founded the mighty Icon Vs. Icon more than a decade ago. Along the way, he’s assembled an amazing group of like-minded individuals to spread the word on some of the most unique people and projects on the pop culture landscape.

source

U.S. Job Growth Slows From Red-Hot Pace – The New York Times

U.S. Job Growth Slows From Red-Hot Pace  The New York Times
source

Fox News Poll: Kelly holds 8-point lead over Masters in Arizona Senate race – Fox News

This material may not be published, broadcast, rewritten, or redistributed. ©2022 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
Republican candidates have some convincing to do among their base, as Democrats hold the early advantage in battleground Arizona.
The latest Fox News Poll of Arizona registered voters finds incumbent Democratic Sen. Mark Kelly with an 8 percentage-point lead over Republican Blake Masters (50% to 42%) in the U.S. Senate race.  That’s outside the poll’s margin of error.
Fox News Poll – Senate (Fox News)
ELECTION SPOTLIGHT : ARIZONA SENATE CANDIDATES MASTERS AND KELLY TALK INFLATION REDUCTION ACT, MIDTERM OPPONENT
Kelly’s support is just shy of his 2020 vote share when he narrowly beat Republican Martha McSally (51.2% to 48.8%). 
Kelly’s lead comes from 95% support among Democrats.  Masters fails to garner the same party loyalty, as only 82% of Republicans back him, with more than a handful defecting to Kelly (10%).
Voters ages 65 and over (+15) and rural voters (+8), two groups that have leaned more conservative in the past, put their support behind the Democrat.  Men (+8) and White evangelical Christians (+49) break for the Republican.
Whites with no college degree, another voting bloc typically associated with the contemporary GOP base, splits: 45% for Kelly, 46% for Masters.
The gender gap is prevalent, with more men supporting Masters by 8 points and more women preferring Kelly by 23 points. 
That gap could come from Arizona women disapproving of the U.S. Supreme Court overturning Roe v. Wade by more than 30 points (30% approve vs. 62% disapprove), while men split (45-46%).  Overall, a narrow majority disapproves of the ruling (37-54%).
Fox News Poll – AZ Roe v Wade (Fox News)
Meanwhile, Masters has an enthusiasm problem, as about 4 in 10 of his voters (43%) support him enthusiastically, while two-thirds (65%) of Kelly’s are excited about him.
When it comes to personal ratings, Kelly is in the green by 6 points (51% favorable vs. 45% unfavorable), and Masters is underwater by 4 points (40% vs. 44%).  Another 16% can’t rate Masters one way or the other.
Former President Donald Trump endorsed Masters in early June, and when asked by Fox News Digital last week about supporting Trump for a 2024 run, the GOP candidate said, “Four more years of that? Sign me up.” The survey finds 42% are extremely or very concerned he is too close to the former president. 
When asked about supporting President Joe Biden, Kelly answered that he’s focused on an “election in 3 months,” not 2024.  A smaller number, 36%, feel Kelly is too close to Biden. 
Fox News Poll – Ties to Presidents (Fox News)
Favorable ratings for both Biden and Trump are underwater, with views of Biden (44% favorable vs. 54% unfavorable) more negative than Trump’s (47-52%).  Still, dislike of Biden doesn’t translate directly into support for the GOP candidate, as 75% of Biden unfavorable voters go for Masters, while a whopping 89% of Trump unfavorable voters favor Kelly.
“Constituencies that have propelled Republicans to victory in other states are splitting in Arizona, especially Whites with no college degree and rural voters,” says Republican pollster Daron Shaw who conducts the Fox News Poll alongside Democrat Chris Anderson. “Kelly isn’t dominating among suburban voters or other swing groups, but he doesn’t have to because he is running so well with GOP groups.”
It’s not all bad news for Masters, as more of his voters (77%) than Kelly’s (71%) are extremely motivated to head to the ballot box this November and slightly more are certain they will indeed vote (93% Masters voters will vs. 89% for Kelly).
The 2020 presidential election saw a close race in Arizona, with Biden winning the Grand Canyon state by less than a percentage point, sparking a fierce debate over the validity of the results.
The poll, released Thursday, shows over half of Arizona voters are extremely or very confident votes in their state were counted accurately and cast legitimately in 2020 (53%), however, a robust 45% minority aren’t so sure.
Fox News – 2020 Election Counting in AZ (Fox News)
Seventy-nine percent of Democrats are extremely confident in the results. On the other side, 50% of Republicans are not at all confident in the legitimacy of the 2020 results.
In March, Arizona GOP leadership passed a law requiring federal voters to provide proof of citizenship before registering to vote in the next presidential elections. The Department of Justice sued Arizona over this law in July.
Unsurprisingly, election integrity/voting rights is one of the top issues to Arizona voters.
Sixteen percent say election integrity and voting rights will be the most important issue to their Senate vote, tied with abortion.  The only issues more important are border security and inflation, also tied at 20% apiece.  Guns (6%), education (6%), climate change (5%), and crime (1%) are in the single digits when it comes to importance.
Fox News Poll – AZ Issues (Fox News)
Arizona voters are three times more likely to say their financial situation is worse (44%) than better (15%) compared to two years ago.  Forty percent say it’s about the same.
Of the top four vote issues, Kelly is the choice among abortion and election integrity voters, while Masters is preferred among those prioritizing border security and inflation.
“Inflation may not be the preeminent issue in Arizona like other places because border security is a top issue here,” says Anderson.  “And the reverberations from 2020 may also be stronger here, making election integrity a powerful polarizing issue, as well as strongly held views of Trump motivating both sides.”
The same demographic trends apply to the gubernatorial race where there is a smaller gap, but still an edge for current Arizona Secretary of State and Democratic candidate Katie Hobbs over Republican Kari Lake (47% to 44%).  That’s within the margin of error.
Fox News Poll – AZ Gov (Fox News)
SEN. KELLY SAYS BIDEN ADMIN DOESN’T HAVE PLAN IN PLACE FOR LIFTING TITLE 42: ‘IT’S GOING TO BE A CRISIS’ 
Hobbs receives more support among Democrats (92%) than Lake does of Republicans (84%).
CLICK HERE TO GET THE FOX NEWS APP
Neither gubernatorial candidate breaks 50% when it comes to favorability ratings, but Hobbs is in positive territory by 8 points (46% favorable, 38% unfavorable) while Lake is underwater by 5 (41-46%).
CLICK HERE FOR TOPLINE AND CROSSTABS.
Conducted August 12-16, 2022 under the joint direction of Beacon Research (D) and Shaw & Company (R), this Fox News Poll includes telephone interviews (landline and cellphone) with live interviewers among 1,012 Arizona voters, randomly selected from a statewide voter file.  Interview were conducted by bilingual interviewers and respondents were given the option of completing the survey in English or Spanish. The poll has a margin of sampling error of plus or minus three percentage points for all registered voters.
This material may not be published, broadcast, rewritten, or redistributed. ©2022 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

source

Chip company Micron announces multibillion-dollar facility in Boise – Capital Public Radio News

CapRadio
By Sáša Woodruff | BSPR
Friday, September 2, 2022

Copyright 2022 Boise State Public Radio News. To see more, visit Boise State Public Radio News.

Micron Technology announces a $15 billion manufacturing plant for Boise, the largest private investment ever in Idaho. CHIPS Act incentives and state help are credited for thousands of new jobs.
RACHEL MARTIN, HOST:
Three weeks after President Biden signed the CHIPS Act to boost domestic production of semiconductors, chip company Micron has announced that it is building a $15 billion manufacturing plant in Boise, Idaho. Boise State Public Radio’s Sasa Woodruff reports.
SASA WOODRUFF, BYLINE: Fifteen billion dollars is a huge investment for Boise, where Micron is based. Mayor Lauren McLean says the company is promising 2,000 jobs here and expects its plant to create 17,000 nationwide.
(SOUNDBITE OF ARCHIVED RECORDING)
LAUREN MCLEAN: It’s a big day for the city of Boise, and I’d say it’s a big day for our state and our nation too.
WOODRUFF: Emilie Simons, assistant White House press secretary, says the new memory chip plant will help fix supply shortages that emerged during the pandemic.
EMILIE SIMONS: We saw this in real life when cars became harder to find, dishwashers were more on back order.
WOODRUFF: Simons says the CHIPS and Science Act was crucial to Micron building the new plant in the U.S.
SIMONS: They were looking at opportunities in Europe and in other countries where countries had already passed legislation that was meeting them halfway.
WOODRUFF: Micron will fund science and technology education in Idaho from elementary school through college, says Chief People Officer April Arnzen.
APRIL ARNZEN: As you can imagine, hiring another 2,000 direct employees to Micron is going to require a lot of support from our educators in Idaho and across the region.
WOODRUFF: Idaho ranks last in the country for per student spending. Micron also plans to partner with Boise on housing, where prices skyrocketed during the pandemic.
ARNZEN: Housing is a challenge, and we continue to partner with the mayor’s office and others to support all of these jobs that we’re bringing to Boise.
WOODRUFF: Micron says this investment in Boise is the initial phase of a $40 billion plan to build memory fabrication plants in other parts of the country.
For NPR News, I’m Sasa Woodruff in Boise.
(SOUNDBITE OF MUSIC) Transcript provided by NPR, Copyright NPR.
CapRadio provides a trusted source of news because of you.  As a nonprofit organization, donations from people like you sustain the journalism that allows us to discover stories that are important to our audience. If you believe in what we do and support our mission, please donate today.
Delivered to your inbox every Friday.
Check out a sample ReCap newsletter.
Thank you for signing up for the ReCap newsletter! We'll send you an email each Friday with the top stories from CapRadio.
Northern California wildfires: Where to find updates on air quality, evacuations, and official information
Coronavirus FAQ: Does a faint line on a self-test mean I'm barely contagious?
Here are the major bills passed by California lawmakers in 2022
California coronavirus updates: US life expectancy fell by three years in 2021
Standard or daylight saving time? California changes its plans again after Congressional resolution.
7055 Folsom Boulevard
Sacramento, CA 95826-2625
CapRadio stations are licensed to California State University, Sacramento. © 2022, Capital Public Radio. All Rights Reserved. Privacy Policy | Website Feedback FCC Public Files: KXJZ KKTO KUOP KQNC KXPR KXSR KXJS. For assistance accessing our public files, please call 916-278-8900 or email us.

source

The Wonder Years on their new album, The Hum Goes On Forever – Guitar.com

The dad-punk heroes embrace the energy of the past and meld it with the esoteric influences of their present on new album The Hum Goes On Forever, we caught up with guitarists, Matt Brasch, Casey Cavaliere and Nick Steinborn to talk weird Fender distortion pedals and the power of being in the room.
The pandemic stopped a lot of bands in their tracks. Some of them were able to regroup quickly and make new records to fill the sterile air. Others decompressed after being forced off the road for the first time in decades. The Wonder Years, an undertaking founded upon ideals of compassion and connection, stared down their own mortality as a group. If they couldn’t play live, did they still have a purpose?
“You start to almost lose the thread of why you do it and who you are,” vocalist Dan Campbell recently told Kerrang!. But the record they made during that time is one hell of a response to that line of existential questioning. The Hum Goes on Forever is a deep dive into anxiety and uncertainty, revolving chiefly around Campbell’s experiences as a father, but it is delivered with iron resolve. It seems to suggest that the Wonder Years’ purpose is simply to keep going. “When I was 17, I wrote a song about how I’m drinking kerosene to light a fire in my gut,” Campbell sings at one point. “And I’ll be coughing out embers for decades to come.” There’s no lie there.

The Wonder Years’ story arc to this point has been defined by growth plus changing priorities and, fittingly, they haven’t made a record like this before, one that squares the hook-driven immediacy of their early work with the sweeping, ambitious rock songs that Campbell has become a master at delivering. It’s balanced in a way that suggests they’ve wrestled with their legacy plenty over the past couple of years, and also that their experiment of recording two songs while cosplaying as their former selves helped tap into something they’d not thought about for a while.
“As the people who have lived through it, I think there’s an interesting energy where there’s the question of your older works being like a different band,” guitarist Casey Cavaliere says. “Every band evolves, right? We wouldn’t have gotten here if we didn’t have those albums where it was more about the energy and how fast we can play.
“We were in a time and place in our career where we were coming out of that high energy, DIY floor show environment. I think as we’ve gone on, a lot more nuanced influences have started to be pulled in from every direction. So far, the response with a lot of the new songs is that it feels both nostalgic and refreshing. I mean, that’s the best we can hope for.”
The Wonder Years - The Hum Goes On
The Philadelphia group’s three guitarists join the Zoom call in intervals. Matt Brasch, who plays a Les Paul Studio in tandem with a Kurt Cobain Jaguar, is there early, and when Cavaliere, another Les Paul Studio guy, joins a couple of minutes later the pair are obviously stoked to see each other. “Matt Brasch, long time no see!” Cavaliere says excitedly, having swapped Philly for Atlanta in 2021.
When Nick Steinborn, whose go-to is a 2015 American Deluxe Tele, checks in, the whole mood shifts and all of a sudden there are simply three old friends nerding out over gear. The conversation wanders here to there, spiralling through heads, pedals, stupid ideas that turned out to be good ideas, and a broken down piece of trash dubbed ‘Thor’s Hammer’ by the band’s regular producer Steve Evetts.
“It’s a Fender distortion from the 80s, they’re impossible to find,” Steinborn says. “I’ve looked. It was impossible for me to find information on it for a while. The pedal has a knob on it that adjusts the EQ balance versus the non EQ balance. You go one way and it turns the volume up with EQ, and the other way is without EQ. It’s the most insane distortion. Any really fucked up guitar tone with Steve is probably that.”

The Wonder Years
Image: Press

“Thor’s Hammer has been on every record, I think it’s just a glorious mistake,” Cavaliere adds. “I think it’s just gotten so twistedly broken over the years of being thrown back on the shelf, stepped on, kicked over. There’s some weird messed up magic in that pedal – even if you bought another one, I am so positive it would not do the same thing.”
Thor’s Hammer isn’t just a curio, though. There’s a lot of gnarly stuff on The Hum Goes on Forever. Over the years, Brasch, Cavaliere and Steinborn have become dialled in to the emotional squalls of Campbell’s writing. As he has developed further as a storyteller, scratching away the pop-punk veneer to reveal lyrics that meld Craig Finn-style parables with vivid first-person writing, his bandmates have found ways to adapt, retreating to a whisper one moment before bringing out the blood and thunder the next.
“I think we’ve grown a lot together,” Brasch says. “We all have a lot of different influences. We’re not just going to write fast, super loud songs all the time, we want to have a dynamic record. We’ve all built off one another and built off our influences in other bands, movies, books. I think it’s just a matter of growing up and really finding your sound after a while. We all play off of one another, and that’s what makes our band our band.”

Matching Campbell blow for blow is both a creative and technical challenge. Cardinals II, a sequel to a song on 2015’s somewhat underrated No Closer to Heaven, is truly crushing. “I can’t protect you, I had my chance and I fucked it up,” Campbell yells, and the guitars buck and kick, landing deep in your chest. On Oldest Daughter, which serves as a continuation of a story from 2013’s The Greatest Generation, the band tumble into the sort of half-time thrash that has become a pillar of their sound, viscerally dredging up the fear and hopelessness in Campbell’s words while making the whole thing sound impossibly anthemic.
For that to work, Steinborn and Evetts had to bake in the glow of a cranked Sunn Concert Lead. “All the bass is rammed through that, and it sounds fucking awesome, but Oldest Daughter‘s actually that on 10,” Steinborn recalls. “The A/C was broken in the room, so we were just sweating all day, smelling 70s solder as it’s burning our brains. You’re curious how to get that sound? That’s it.” Brasch wandered into the studio the next day and freaked: “I was like, ‘Steve, something’s on fire, man.’”

A post shared by The Wonder Years (@thewonderyearsband)

As powerful and sure of itself as The Hum Goes on Forever sounds, its writing process was littered with challenges, the pandemic chief among them. The Wonder Years might run off being able to see the whites of their audience’s eyes night after night, but their creative process is founded on trust and communication stemming from a decades-long friendship. “We discovered how hard it was to write with Dan hiding in my laundry room with the door shut, and all of us with masks on,” Steinborn says. Brasch takes over: “We all keep our emotions on our faces.”
Finding that they couldn’t get moving, the band decided to rent a house in the sticks at the height of winter 2021 and go full bubble. After quarantining for 14 days beforehand, they found that being in close quarters, letting ideas bounce around while they cooked or hung out, allowed for some of their muscle memory to kick into action.
“It was very easy for Dan to just go pick up the acoustic, have us right there, and just talk through it,” Cavaliere says. “For us as guitar players, too, it was really crucial. We’ve learned to sit down so that we can be like, ‘Nick, let’s deconstruct what was happening there when we were all playing as a band so that we can make sure we’re lining up and complementing each other.’”

The rest of the pieces fell into place over the following six months in scattered writing conflabs and sessions with Evetts and Will Yip. The level of care behind this drawn out spell of creativity is reflected in the way The Hum Goes on Forever moves – surging from each highpoint in search of another one that says something different about how the Wonder Years came to be where they are today. “If the song makes it through the six of us in a room, it’s always going to be a Wonder Years song,” Cavaliere says. “This record, and how it came together, was us trying to trust that fact and not overthink it.
“When we were much younger, it was, ‘Does this rip? Is it fast? Is it loud? Yes, let’s go.’ And people say bands overthink things, or try and get too complex for no good reason, later in their career. We didn’t want to necessarily do that with this record, too. We wanted to make room for the on-the-ground-in-a-sea-of-pedals experimentation, but make sure it had a reason, it had a place, and had an intention.”
The Wonder Years’ The Hum Goes on Forever is out on September 23 through Hopeless Records.
Guitar.com is the world’s leading authority and resource for all things guitar. We provide insight and opinion about gear, artists, technique and the guitar industry for all genres and skill levels.
© 2022 Guitar.com is part of NME Networks.

source

'Extraordinary Attorney Woo' studio rejects Netflix's offer for original series – 코리아타임스

Millions in need of aid as floods hit Pakistan
Our children deserve the best
Ice is melting, land is burning
Tottenham 6-3 Team K League
Afghanistan earthquake killed more than 1,000

source

New application filed for mixed-use project on Harrison Street that was previously denied by city – Pleasanton Weekly

News
by / Pleasanton Weekly
Uploaded: Wed, Aug 31, 2022, 6:48 pm 20
Time to read: about 5 minutes
Artist’s rendering of the development project that is being reviewed for construction at 4884 Harrison St. (Image courtesy of Julie Testa)
A revised application to construct a five-story, mixed-use building on the edge of downtown Pleasanton with no onsite parking was sent again to city staff for approval months after an initial rejection — and in light of recent state housing laws, residents and city leaders will likely not be able to push back.
If city staff don’t find any technical issues with the project, the proposed affordable housing project will be on track to be built at 4884 Harrison St., near the Pleasanton Public Library.
“I want affordable housing, but it should be something that fits in with the neighborhood and the fact of no onsite parking. I just don’t know how it’s gonna even work at all,” Mary Reding, a 43-year resident of Harrison Street, told the Weekly.
The project, as proposed by Encino-based AMG Associates, LLC, would consist of 46 residential units, including a mix of studio, one- and two-bedroom units, and 1,400 square feet of ground floor retail commercial space, according to a notice letter sent out to residents from the city. All of the housing units would be deed-restricted as affordable.
Senate Bill 35 is one of the two main recent housing laws that now require California cities and counties to streamline review and approval of eligible affordable housing projects, exempting such projects from full environmental review under the California Environmental Quality Act.
Help sustain the local news you depend on.
Your contribution matters. Become a member today.
The Harrison Street project did not originally qualify for ministerial approval under SB 35 earlier in the year because it failed to address issues about fire department access and sidewalk width, according to city officials. After the initial denial the city did anticipate the application to come back once the corrections to the health and safety codes were made.
Part of the bill that led to choosing the Harrison Street location was due to the project’s location within half a mile of the downtown Altamont Corridor Express train station. Because of that close distance to major public transit, the state law specifies the city may not require the project to provide onsite parking and it can’t impose any limit on the density of the project.
Artist’s rendering of the development project that is being reviewed for construction at 4884 Harrison St. (Image courtesy of Julie Testa)
“It is affordable housing, which I think we need,” Reding said. “I have grandchildren and nieces and nephews that I would love for them to be able to have a home here in Pleasanton and be affordable, but a five-story building with no on-site parking, it’s just not appropriate.”
She said that close proximity to the station is not a good enough reason to build the project because that station is not really being used as much as it was before the pandemic, meaning people will be driving instead, which in turn will lead to more traffic.
“Since COVID, there’s probably maybe 20 cars in that parking lot whereas before COVID, the whole parking lot was filled. So that’s the reason why I’m upset about it,” she said. “(The state) did not think about how this SB 35 was going to impact small neighborhoods like Harrison Street.”
Stay informed
Get daily headlines sent straight to your inbox in our Express newsletter.
Stay informed
Get daily headlines sent straight to your inbox in our Express newsletter.
Mayor Karla Brown told the Weekly she thinks the Harrison project could be a good fit for downtown Pleasanton but is also concerned about the zero parking that could lead to overflow of cars in neighboring communities and streets and how that could affect the neighboring developments.
Councilmember Jack Balch echoed that sentiment, saying that the parking allowance would have made more sense if it was a BART station, because then more people would be inclined to use that to get around.
“We definitely have a need for affordable housing in our community and I understand what the state is trying to achieve, but when we look at it at this site and we look at the waiving of parking, because it’s near mass transit, I think that the state probably did not see these unintended consequences,” Balch said.
But the main point of concern in SB 35 for many residents and city leaders is the fact that due to the limitations on local control — a term used to describe the power cities have in setting and enforcing zoning and land regulations — the city has no discretion in reviewing the Harrison project.
Also, per the specific language of SB 35, no public hearings or review by the Planning Commission or City Council are allowed.
Most Viewed Stories
■ New application filed for mixed-use project on Harrison Street that was previously denied by city
■ Amador Valley alum killed in car crash near Arnold
■ Pleasanton high school football preview
■ Omicron-specific COVID booster vaccines could be available by Labor Day following FDA approval
■ Portraits for Patriots
Most Viewed Stories
■ New application filed for mixed-use project on Harrison Street that was previously denied by city
■ Amador Valley alum killed in car crash near Arnold
Councilmember Julie Testa said she disagrees with the city effectively having no say and is advocating for the city to push back on the new state laws so that cities can regain power over making these decisions.
“The city, myself, and everyone I know that I work with supports affordable housing,” Testa said. “It should be affordable housing done in a way that the local municipality has input on, where we would decide how and where it fits in this community.”
The project feels like it got an “over-the-counter approval”, according to Testa. She said it’s not that she is against affordable housing, she just wants it built in a more appropriate location.
“If it were located somewhere more appropriately, it would be welcomed because we do welcome an affordable housing project,” Testa said. “But this one in that location is absolutely not welcome. It doesn’t fit, it will cause a tremendous amount of damage, it will cost the city a lot, monetarily.”
Testa added that the “Our Neighborhood Voices” initiative, which she has backed since the project first came to light, is promoting a statewide initiative to go on the ballot in 2024 to neutralize these kinds of laws and bring back local control.
“It will give cities an opportunity to say for a project like this. This doesn’t fit in this location, but it would fit somewhere else,” she said.
She is also asking the city to join with other cities across the state in a class-action lawsuit that will push back on the state in their intrusion of local control.
But Balch said that looking to regain local control is a complex and nuanced issue because of the history Pleasanton has with housing lawsuits such as the 2006 lawsuit when the city was sued by Urban Habitat, an Oakland-based nonprofit, over the city’s 29,000-unit housing cap — which the city lost and cost millions of dollars.
“If we don’t push forward to achieve an acceptable housing element and rezone the properties, we are facing the penalties,” Balch said. “I understand the challenge to additional housing units in our community when we’re facing so many things, but we also have to be careful with the lawsuit costs.”
He said with the significant amount of jobs and a housing imbalance, it is important to continue affordable housing growth to attract younger residents, which will in turn help grow the city’s economy.
“Every time someone talks to me … about local control, everyone is fearful that their slice of the pie has to get smaller so that someone has an opportunity to buy a home, or raise a family in Pleasanton, and I just don’t believe that,” Balch said. “I believe that the entire pie can grow, so that we can provide opportunities, and basically hope for young families.”
The other state regulation at play is the housing density bonus law, which requires the city, “to approve requested waivers and concessions from established development standards if doing so would improve the financial feasibility of the project,” according to the notice letter for the Harrison application.
The project has requested concessions for the front setback, floor-area ratio and common area open space requirements — a waiver that the city is obligated under these laws to provide.
“City staff is reviewing the application for conformance to the applicable standards set forth in State law and the Pleasanton Municipal Code and may only deny the project if it would not be in conformance to any objective development standards,” according to the notice letter.
Staff have until Sept. 16 to issue an approval letter so that the project can move forward into the next stage of the building permit application process.
A front row seat to local high school sports.
Check out our new newsletter, the Playbook.
Follow PleasantonWeekly.com and the Pleasanton Weekly on Twitter @pleasantonnews, Facebook and on Instagram @pleasantonweekly for breaking news, local events, photos, videos and more.

by / Pleasanton Weekly
Uploaded: Wed, Aug 31, 2022, 6:48 pm

A revised application to construct a five-story, mixed-use building on the edge of downtown Pleasanton with no onsite parking was sent again to city staff for approval months after an initial rejection — and in light of recent state housing laws, residents and city leaders will likely not be able to push back.

If city staff don’t find any technical issues with the project, the proposed affordable housing project will be on track to be built at 4884 Harrison St., near the Pleasanton Public Library.

“I want affordable housing, but it should be something that fits in with the neighborhood and the fact of no onsite parking. I just don’t know how it’s gonna even work at all,” Mary Reding, a 43-year resident of Harrison Street, told the Weekly.

The project, as proposed by Encino-based AMG Associates, LLC, would consist of 46 residential units, including a mix of studio, one- and two-bedroom units, and 1,400 square feet of ground floor retail commercial space, according to a notice letter sent out to residents from the city. All of the housing units would be deed-restricted as affordable.

Senate Bill 35 is one of the two main recent housing laws that now require California cities and counties to streamline review and approval of eligible affordable housing projects, exempting such projects from full environmental review under the California Environmental Quality Act.

The Harrison Street project did not originally qualify for ministerial approval under SB 35 earlier in the year because it failed to address issues about fire department access and sidewalk width, according to city officials. After the initial denial the city did anticipate the application to come back once the corrections to the health and safety codes were made.

Part of the bill that led to choosing the Harrison Street location was due to the project’s location within half a mile of the downtown Altamont Corridor Express train station. Because of that close distance to major public transit, the state law specifies the city may not require the project to provide onsite parking and it can’t impose any limit on the density of the project.

“It is affordable housing, which I think we need,” Reding said. “I have grandchildren and nieces and nephews that I would love for them to be able to have a home here in Pleasanton and be affordable, but a five-story building with no on-site parking, it’s just not appropriate.”

She said that close proximity to the station is not a good enough reason to build the project because that station is not really being used as much as it was before the pandemic, meaning people will be driving instead, which in turn will lead to more traffic.

“Since COVID, there’s probably maybe 20 cars in that parking lot whereas before COVID, the whole parking lot was filled. So that’s the reason why I’m upset about it,” she said. “(The state) did not think about how this SB 35 was going to impact small neighborhoods like Harrison Street.”

Mayor Karla Brown told the Weekly she thinks the Harrison project could be a good fit for downtown Pleasanton but is also concerned about the zero parking that could lead to overflow of cars in neighboring communities and streets and how that could affect the neighboring developments.

Councilmember Jack Balch echoed that sentiment, saying that the parking allowance would have made more sense if it was a BART station, because then more people would be inclined to use that to get around.

“We definitely have a need for affordable housing in our community and I understand what the state is trying to achieve, but when we look at it at this site and we look at the waiving of parking, because it’s near mass transit, I think that the state probably did not see these unintended consequences,” Balch said.

But the main point of concern in SB 35 for many residents and city leaders is the fact that due to the limitations on local control — a term used to describe the power cities have in setting and enforcing zoning and land regulations — the city has no discretion in reviewing the Harrison project.

Also, per the specific language of SB 35, no public hearings or review by the Planning Commission or City Council are allowed.

Councilmember Julie Testa said she disagrees with the city effectively having no say and is advocating for the city to push back on the new state laws so that cities can regain power over making these decisions.

“The city, myself, and everyone I know that I work with supports affordable housing,” Testa said. “It should be affordable housing done in a way that the local municipality has input on, where we would decide how and where it fits in this community.”

The project feels like it got an “over-the-counter approval”, according to Testa. She said it’s not that she is against affordable housing, she just wants it built in a more appropriate location.

“If it were located somewhere more appropriately, it would be welcomed because we do welcome an affordable housing project,” Testa said. “But this one in that location is absolutely not welcome. It doesn’t fit, it will cause a tremendous amount of damage, it will cost the city a lot, monetarily.”

Testa added that the “Our Neighborhood Voices” initiative, which she has backed since the project first came to light, is promoting a statewide initiative to go on the ballot in 2024 to neutralize these kinds of laws and bring back local control.

“It will give cities an opportunity to say for a project like this. This doesn’t fit in this location, but it would fit somewhere else,” she said.

She is also asking the city to join with other cities across the state in a class-action lawsuit that will push back on the state in their intrusion of local control.

But Balch said that looking to regain local control is a complex and nuanced issue because of the history Pleasanton has with housing lawsuits such as the 2006 lawsuit when the city was sued by Urban Habitat, an Oakland-based nonprofit, over the city’s 29,000-unit housing cap — which the city lost and cost millions of dollars.

“If we don’t push forward to achieve an acceptable housing element and rezone the properties, we are facing the penalties,” Balch said. “I understand the challenge to additional housing units in our community when we’re facing so many things, but we also have to be careful with the lawsuit costs.”

He said with the significant amount of jobs and a housing imbalance, it is important to continue affordable housing growth to attract younger residents, which will in turn help grow the city’s economy.

“Every time someone talks to me … about local control, everyone is fearful that their slice of the pie has to get smaller so that someone has an opportunity to buy a home, or raise a family in Pleasanton, and I just don’t believe that,” Balch said. “I believe that the entire pie can grow, so that we can provide opportunities, and basically hope for young families.”

The other state regulation at play is the housing density bonus law, which requires the city, “to approve requested waivers and concessions from established development standards if doing so would improve the financial feasibility of the project,” according to the notice letter for the Harrison application.

The project has requested concessions for the front setback, floor-area ratio and common area open space requirements — a waiver that the city is obligated under these laws to provide.

“City staff is reviewing the application for conformance to the applicable standards set forth in State law and the Pleasanton Municipal Code and may only deny the project if it would not be in conformance to any objective development standards,” according to the notice letter.

Staff have until Sept. 16 to issue an approval letter so that the project can move forward into the next stage of the building permit application process.

A revised application to construct a five-story, mixed-use building on the edge of downtown Pleasanton with no onsite parking was sent again to city staff for approval months after an initial rejection — and in light of recent state housing laws, residents and city leaders will likely not be able to push back.
If city staff don’t find any technical issues with the project, the proposed affordable housing project will be on track to be built at 4884 Harrison St., near the Pleasanton Public Library.
“I want affordable housing, but it should be something that fits in with the neighborhood and the fact of no onsite parking. I just don’t know how it’s gonna even work at all,” Mary Reding, a 43-year resident of Harrison Street, told the Weekly.
The project, as proposed by Encino-based AMG Associates, LLC, would consist of 46 residential units, including a mix of studio, one- and two-bedroom units, and 1,400 square feet of ground floor retail commercial space, according to a notice letter sent out to residents from the city. All of the housing units would be deed-restricted as affordable.
Senate Bill 35 is one of the two main recent housing laws that now require California cities and counties to streamline review and approval of eligible affordable housing projects, exempting such projects from full environmental review under the California Environmental Quality Act.
The Harrison Street project did not originally qualify for ministerial approval under SB 35 earlier in the year because it failed to address issues about fire department access and sidewalk width, according to city officials. After the initial denial the city did anticipate the application to come back once the corrections to the health and safety codes were made.
Part of the bill that led to choosing the Harrison Street location was due to the project’s location within half a mile of the downtown Altamont Corridor Express train station. Because of that close distance to major public transit, the state law specifies the city may not require the project to provide onsite parking and it can’t impose any limit on the density of the project.
“It is affordable housing, which I think we need,” Reding said. “I have grandchildren and nieces and nephews that I would love for them to be able to have a home here in Pleasanton and be affordable, but a five-story building with no on-site parking, it’s just not appropriate.”
She said that close proximity to the station is not a good enough reason to build the project because that station is not really being used as much as it was before the pandemic, meaning people will be driving instead, which in turn will lead to more traffic.
“Since COVID, there’s probably maybe 20 cars in that parking lot whereas before COVID, the whole parking lot was filled. So that’s the reason why I’m upset about it,” she said. “(The state) did not think about how this SB 35 was going to impact small neighborhoods like Harrison Street.”
Mayor Karla Brown told the Weekly she thinks the Harrison project could be a good fit for downtown Pleasanton but is also concerned about the zero parking that could lead to overflow of cars in neighboring communities and streets and how that could affect the neighboring developments.
Councilmember Jack Balch echoed that sentiment, saying that the parking allowance would have made more sense if it was a BART station, because then more people would be inclined to use that to get around.
“We definitely have a need for affordable housing in our community and I understand what the state is trying to achieve, but when we look at it at this site and we look at the waiving of parking, because it’s near mass transit, I think that the state probably did not see these unintended consequences,” Balch said.
But the main point of concern in SB 35 for many residents and city leaders is the fact that due to the limitations on local control — a term used to describe the power cities have in setting and enforcing zoning and land regulations — the city has no discretion in reviewing the Harrison project.
Also, per the specific language of SB 35, no public hearings or review by the Planning Commission or City Council are allowed.
Councilmember Julie Testa said she disagrees with the city effectively having no say and is advocating for the city to push back on the new state laws so that cities can regain power over making these decisions.
“The city, myself, and everyone I know that I work with supports affordable housing,” Testa said. “It should be affordable housing done in a way that the local municipality has input on, where we would decide how and where it fits in this community.”
The project feels like it got an “over-the-counter approval”, according to Testa. She said it’s not that she is against affordable housing, she just wants it built in a more appropriate location.
“If it were located somewhere more appropriately, it would be welcomed because we do welcome an affordable housing project,” Testa said. “But this one in that location is absolutely not welcome. It doesn’t fit, it will cause a tremendous amount of damage, it will cost the city a lot, monetarily.”
Testa added that the “Our Neighborhood Voices” initiative, which she has backed since the project first came to light, is promoting a statewide initiative to go on the ballot in 2024 to neutralize these kinds of laws and bring back local control.
“It will give cities an opportunity to say for a project like this. This doesn’t fit in this location, but it would fit somewhere else,” she said.
She is also asking the city to join with other cities across the state in a class-action lawsuit that will push back on the state in their intrusion of local control.
But Balch said that looking to regain local control is a complex and nuanced issue because of the history Pleasanton has with housing lawsuits such as the 2006 lawsuit when the city was sued by Urban Habitat, an Oakland-based nonprofit, over the city’s 29,000-unit housing cap — which the city lost and cost millions of dollars.
“If we don’t push forward to achieve an acceptable housing element and rezone the properties, we are facing the penalties,” Balch said. “I understand the challenge to additional housing units in our community when we’re facing so many things, but we also have to be careful with the lawsuit costs.”
He said with the significant amount of jobs and a housing imbalance, it is important to continue affordable housing growth to attract younger residents, which will in turn help grow the city’s economy.
“Every time someone talks to me … about local control, everyone is fearful that their slice of the pie has to get smaller so that someone has an opportunity to buy a home, or raise a family in Pleasanton, and I just don’t believe that,” Balch said. “I believe that the entire pie can grow, so that we can provide opportunities, and basically hope for young families.”
The other state regulation at play is the housing density bonus law, which requires the city, “to approve requested waivers and concessions from established development standards if doing so would improve the financial feasibility of the project,” according to the notice letter for the Harrison application.
The project has requested concessions for the front setback, floor-area ratio and common area open space requirements — a waiver that the city is obligated under these laws to provide.
“City staff is reviewing the application for conformance to the applicable standards set forth in State law and the Pleasanton Municipal Code and may only deny the project if it would not be in conformance to any objective development standards,” according to the notice letter.
Staff have until Sept. 16 to issue an approval letter so that the project can move forward into the next stage of the building permit application process.
I agree with Julie Testa. We need more affordable housing, but the location in downtown and no on-site parking is not appropriate and our Fire Department does not have a vehicle that can reach the top of the proposed building.
Maybe the design requires firefighting sprinkler system!
If Julie Testa feels its not the right location, where would she suggest?
Skynet, have you looked at the artist’s rendering—5 stories next to small cottages. Surely you don’t think it belongs there looming over those homes making backyards feel like 1000 eyes are watching?
I agree with Julie. This is not a good fit for Harrison Street. It looks out of place and will take alway the charm of the quaint downtown neighborhood!
The state needs to encourage businesses to open offices in other areas besides the already crowded urban areas where all the jobs are. Instead they are forcing cities to build more housing, without any thought how well it will work.
No parking is going to cause big problems for the 5-story building’s residents, and their neighbors. The state legislators and the governor are Urban Utopians who may have good intentions, but no realistic plan for the problems this will cause. And cities are going to be left to clean up the mess and pay for it.
When they passed these anti-zoning laws, every parcel in the city got more valuable because now more lot coverage is legal, making all housing much more expensive – the opposite of what they were trying to do.

My wife and I just returned from a trip which included a tour of the city of Prague. The tour guide pointed out a large block of housing units that were 4 and 5 stories with a very plain and rather unattractive exterior. The proposal that is shown remined me of the units we saw in Prague. The tour guide stated that they were required and built when Prague was under communist control from Russia. It seems that the state of California is following a similar pattern. Keep voting for the same people in our state legislature and we will continue to be subject to their demands.
Dear Mr. Austin,
Fire Sprinklers Save Lives:
Since 2012, ALL new and most significant remodel Residential buildings are required by California law to have fire sprinkler systems, including apartment buildings, care facilities, even single family residences.
Livermore has required sprinklers since the 70’s in all of these.
And it saves lives and taxpayer’s money.
Livermore has allowed more travel time to the fire, and so has been able to avoid building 3 new fire stations as the city expanded, which saves not only the initial cost but significant continuing maintenance costs, well over $1 million per year each.
But often these sprinkler systems are allowed to be very economical, designed mostly to allow people to exit safely, so we still need the fire service to access and finish rescue and fire extinguishment.
Parking is a different BIG factor, will impact the neighbors, as well as future tenants.
Also It is really ugly that they are taking away the BARTD parking lots (originally promised to be free – acquired by eminent domain or taxes) to build housing instead. See how poorly too little parking at transit worked before COVID!
How can we get back Local Control for local issues?
James Art, Fire Protection Engineer
Take a drive around outside the freeways and there’s nothing but land. Land outside Livermore, and near Mountain House. Google satellite and there’s land everywhere. Yet somehow experts can’t figure out how to build enough housing and buying a house is an unaffordable dream for middle class in The Bay Area.
I agree we need more affordable housing. But this? This is going to stick out like a sore thumb. Really wish they’d redesign it so it’s not so out of place.
It’s time to find another space, reduce the height of the building, put the parking underneath instead of retail space. There must be other solutions for this project, we have enough retail downtown we should not try to compete with the over building of Dublin..
I fully understand and agree we need the housing. However, I know how difficult it can be to find parking downtown for appointments, brunch, errands. Homes and businesses with NO designated parking? Crazy!
With the new city hall being built on that little property across from the library and a 5 story built on Harrison street sure looks like future 4-5 story civic center being built in the future after the small homes are knocked down.
Paging Mr. Sullivan,
Here is the real fight. If this project goes through it is going to be eye sore. Not only that the next developer(s) will be looking to steam role the town on another deal before this deal even concludes. A 5 story structure in middle of downtown on single family lot lining Southern Cal developers pockets enabled by Sacramento. The aerial view is straight ugly. It looks like the Arco in Sim City. The developer will probably make $10M on the deal. If this gets approved don’t sell your downtown house but rather start talking to a broker that deals with land sales to developers. Don’t forget to sue. They can’t block access to your house and dirty the place up during construction. Noise pollution….

One final comment. I see the mention of “need” the housing. There are many places around the Bay Area that are better than this location. This is profit on the backs of folks fighting against this for decades. The Bernal property was slated for thousands of homes and folks in town got that whittled down to very little relative. I’d rather that process turned into 50 more housing units than putting up an Arco structure in downtown. I think folks are missing the new laws say you can do this in any neighborhood not just downtown. There are classier operations like Thomas Jane Homes that do a good job of redevelopment. This is not one of those operations.
I favor affordable housing but how foolish in this day and age not to require adequate parking for the tenants. It’s not a good fit for the neighborhood without parking. PLEASE STOP THIS KIND OF FOOLISHNESS.
Robertbush81,

You are right, and this is a real fight. And it’s not just this single project, but the usurpation of local control of land use by the legislature, developers, and the tech industry (who work together to write these laws). This is what Julie Testa has been warning us about and is encouraging the Council to support a state-wide voter initiative to undo these laws.

But there are other “real” fights too. In terms of negative impacts on neighborhoods, air pollution, public health, and traffic, the combination of Costco and the redevelopment of Stoneridge Mall makes this project look like a flea on an elephant. The northwest side of Pleasanton is being turned into a wasteland of overdevelopment to satisfy the RHNA requirements and the city’s desire for commercial and retail tax revenue. If you were a City Councilmember and piled all this development into one corner of town and leave others relatively untouched, you won’t face a widespread voter revolt. In your words THAT is a REAL fight for those neighbors to protect their quality of life.

And at least this little project has deed-restricted affordable housing. All the other high-density housing, including the 1400+ planned for Stoneridge Mall, is for relatively affluent tech workers. It’s not for “our teachers, firefighters, and our kids (unless they are a tech worker)”. So, all this talk from Sacramento and ABAG about RHNA and affordability is hogwash. It’s about tech industry billions at our expense. And to make a point from my recent Op-Ed published in this paper, you can approve a hundred climate action plans that will do nothing about the climate unless you address this type of never-ending growth. So much for Councilmember Balch’s idea about “growing the pie” as the solution. That’s just Chamber of Commerce code language for more growth.

My opinion is Pleasanton has avoided making sure there is affordable housing for lower income ($100K?) people. You just have to look around and see new homes are 2500+ square foot multimillion dollar plus homes. People on this site regularly complain about any sort of higher density apartment type homes.

I think this situation could have been avoided if the citizens over the years would have done the responsible thing and agree to a mix of housing that would have provided housing for all income groups and at the same time be designed to fit in and possibly enhance the community.

I think Pleasanton is receiving the just rewards (penalties?) for the rich snob attitude that has been the norm for decades.
Excellent news! Build more and finally make this over-priced state a place where young families can buy a home and settle. Local government is beholden to a handful of wealthy NIMBY retirees, and I look forward to voting against them in November.
Except the thing is that Julie Testa doesn’t actually believe in affordable housing and has said time and time again she doesn’t think there is a need.

Someone should ask her where she wants affordable housing to go. Given the draft Housing Element sites, it shouldn’t be a hard question. But she won’t tell you. She will only vaguely claim to believe in affordable housing. Affordable housing in another town, mostly likely.

Didn’t getting sued once teach us a lesson?
Don’t miss out on the discussion!
Sign up to be notified of new comments on this topic.
In order to encourage respectful and thoughtful discussion, commenting on stories is available to those who are registered users. If you are already a registered user and the commenting form is not below, you need to log in. If you are not registered, you can do so here.
Please make sure your comments are truthful, on-topic and do not disrespect another poster. Don’t be snarky or belittling. All postings are subject to our TERMS OF USE, and may be deleted if deemed inappropriate by our staff.
See our announcement about requiring registration for commenting.
Home
News
TownSquare
Blogs
A&E
Community Calendar
Home & Real Estate
Express
Special Pubs
Shop Pleasanton
Obituaries
Send News Tips
Subscribe
Circulation & Delivery
Promotions

Livermore Vine
DanvilleSanRamon.com
About Us
Contact Us
Advertising Info
Terms of Use
Privacy Policy
© 2022 PleasantonWeekly.com
All rights reserved.
 
Embarcadero Media
 
PR MediaRelease
Sponsored content
Mobile site
© 2022 PleasantonWeekly.com. All rights reserved.

source

​Music hardware manufacturers WMD to close production this year – Mixmag

The company named “the state of the world” and “global parts shortages” as reasons for its closure
Music hardware manufacturing company WMD has announced it will close production toward the end of 2022, citing the current “state of the world” and “global parts shortages” on its winding down.
After 17 years in operation, WMD will cease production “by the end of 2022”, but added that the company could go on to pastures new and “see what the world has to offer down the road”.
“We’ve been making gear that has pushed the boundaries of electronic music, that’s made its way into the rigs of incredible people we respect, that has allowed them to make music that we cherish, that inspires us to make more gear,” WMD announced on Monday in a statement.
Read this next: What will further chip shortages mean for DJ gear supply?
“Times are tough for everyone. The state of the world has destroyed our sales numbers while operating costs continue to rise. We have many new designs in the pipe that unfortunately cannot be made due to the global parts shortage.”
The leading hardware manufacturer has helped to produce thousands of modular synths, Eurorack modules including oscillators, sequencers, and mixers, and standalone instruments and effects pedals in its 17 years.
“Our company is reliant on the development of new innovative products in the hardware realm and we have watched our lead times for parts get pushed back from months to years, and there is no telling if some will actually come. This makes planning for the future impossible, and new product development unfulfilling,” they added in the statement.
Read this next: Behringer warns of chip shortages due to Ukraine factory shutdown
WMD has now announced three final new products with a limited run of 600 on each module. All other product prices have now been reduced by 30% as the liquidation process begins.
“With the risk of going further in debt with no “end” in sight, we have concluded that the only option is to wind down our production facility, with the plan to close by the end of 2022. We wish that we could keep things going, that we could see another path, but the stress alone has been harmful to our mental health, and our lack of incoming cash is only making it worse.”
Check out WMD’s final product line here, and find the full statement here.
Gemma Ross is Mixmag’s Editorial Assistant, follow her on Twitter
A weekly rundown of everything you need to know in music and culture
Mixmag will use the information you provide to send you the Mixmag newsletter using Mailchimp as our marketing platform. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. By clicking sign me up you agree that we may process your information in accordance with our privacy policy. Learn more about Mailchimp’s privacy practices here.
A weekly rundown of everything you need to know in music and culture
Mixmag will use the information you provide to send you the Mixmag newsletter using Mailchimp as our marketing platform. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. By clicking sign me up you agree that we may process your information in accordance with our privacy policy. Learn more about Mailchimp’s privacy practices here.

source

Jabra Elite 5 Earbuds Review: amazing features, lacking audio – Reviewed

Updated September 1, 2022
Jabra is attempting to thread the needle between the Elite 7 Pro and Elite 4 Active with the Elite 5 (available at Amazon for $149.99), offering earbuds with a whole host of features including IP55 dust and water resistance, hybrid active noise cancelation, wireless charging, good call quality and battery life, and the customization available from Jabra’s excellent Sound+ app. There are some drawbacks in the music and ANC performance compared to competitors, but someone looking for an everyday solution for many situations would do well to check them out.
Recommendations are independently chosen by Reviewed’s editors. Purchases you make through our links may earn us a commission.
About the Jabra Elite 5
What we like
What we don’t like
Should you buy the Jabra Elite 5?
Related content
Deep, customizable features
Top-notch controls
Respectable battery life
Audio quality has flaws
ANC doesn’t match the competition
The Jabra Elite 5 come in a wireless charging case with a total of three ear tip sizes and a USB-C to USB-A charging cable.
The Elite 5 comes in the familiar curved rectangular flip-top case Jabra has used the past few years and supports wireless charging. It’s compact enough to fit into a pocket with a small status LED on the front and USB-C charging port on the back. The packaging it comes in, which is sustainable and recyclable, also contains two additional earbud sizes and a USB-C to USB-A charging cable. Our sample came in an attractive light gold beige color.
A wireless charging case is just one of the many features that comes with the Jabra Elite 5.
The Jabra Sound+ app is one of the best around for its combination of available features, clean organization, and ease of use. The main page shows power percentages of each earbud and the case and has four widgets—sound modes (ANC and transparency control), a 5-band EQ, music presets, and soundscapes—that can be reordered or hidden. Further adjustments can be made within the settings menu.
In the main page sound modes widget, there’s a 5-point slider that changes the intensity of the ANC, letting in more low-end and midrange as the intensity decreases. Additional fine-tuning can be done by navigating to the Active Noise Cancelation submenu in the “Personalize your headset” setting. A 9-point slider allows you to dial in the best noise suppression for your hearing if you find yourself sensitive to the in-ear pressure that can result from ANC. It also allows you to balance it between your two ears if they react differently to the ANC.
Jabra added Bluetooth multipoint to the previous iteration of its earbuds, and it’s present here, too, supporting up to six devices. Jabra has also included auto-pause, which is a welcome addition that works when you remove either the right or left earbud. The music won’t begin again when you put the earbud back in, though. You’ll need to press the unpause button on the right earbud.
Instead of continuing to play, audio can be set to mute when you turn on transparency mode (called HearThrough in the app). I would prefer it paused so I didn’t miss any of my music after re-engaging ANC. There’s also an auto-mute microphone option when you’re on a call and remove an earbud.
The soundscape widget includes 12 different sound loops ranging from pink noise to ocean waves to a crowd that can act as an alternative to music to separate from the world around you. I found the rain and occasional thunder from the “Perfect storm” sound a relaxing respite while taking a short break from work. It’s a nice touch.
While these aren’t a member of Jabra’s workout-focused Active line, the Elite 5 still have gymrat in their DNA. The earbuds are IP55 rated, which is enough to easily handle a workout, and better than other earbuds at or above this price including the Sony Linkbuds S, Beats Fit Pro, and LG Tone Free T90Q. I felt the need to adjust them once during some activity, but they never fell out.
The Elite 5’s touch controls are some of the best on the market.
Other companies, take note: Jabra does controls right. The Elite 5 have tactile buttons that have a satisfying click without having to press them too hard and subsequently drive them further into your ear. A light touch is all it takes.
The button controls can be customized within the Sound+ app depending on function—listening to media, accepting incoming calls, and while you’re on a call—although I never felt the need to further customize the default settings. Everything I needed was already at my fingertips.
Volume controls are always accessible by pressing and holding the right or left button to raise and lower the volume, respectively. The only shared control is for Spotify Tap, which will deactivate your chosen Voice Assistant. For me, that’s an acceptable tradeoff.
The Jabra Elite 5 earbuds get up to 7 hours of battery life with ANC on.
Jabra lists the Elite 5’s battery life with ANC on at seven hours and in our testing, they came in just a little below that. It’s not the most battery life you can find—Sony’s WF-1000XM4 got a full eight in our testing—but it’s more than the aging Apple AirPods Pro and the new Samsung Galaxy Buds 2 Pro that both get less than five hours.
Seven hours with ANC is more than enough to get through the day, and even if you manage to approach the limit, ten minutes in the case will get you another hour of listening time in a pinch.
My voice on calls sounded clear without too many audio artifacts regardless of whether I was inside at my desk or walking down the street with light traffic going by. The mics applied noise compression well to deal with the cars, only occasionally causing a brief cupping sound to happen (as if I put my hands around my mouth to shout) when I quickly changed my orientation. But even then, the change in timbre wasn’t distracting and I was still intelligible.
While there are a ton of features, the Elite 5’s sound has some issues.
There are six music presets and you can save up to 10 custom EQ curves by adjusting the 5-band EQ, hitting save, and assigning a name. With all of those options I was hoping to be able to dial in the sound, but the EQ isn’t targeted enough to address two key issues.
Vocals have a tendency to get buried by the surrounding frequencies on tracks with a rich midrange. As powerful as Zack de la Rocha’s vocals can be, when Rage Against the Machine’s “Sleep Now In The Fire” hits its chorus, he’s no match for Tom Morello’s guitar. Robert Plant has a similar fate in Led Zeppelin’s “Sick Again.” Even though the track isn’t as in your face, his soaring vocals take a back seat as the arrangement gets thicker.
The two midrange adjustments on the EQ—one at 1 kHz and the other at 4 kHz—primarily affect the frequencies around the vocals, which helps take away some of the extra presence of surrounding guitars and strings. But bringing those bands down also brings the vocals down a touch. There’s no way to target the vocals and make sure they soar at all times.
There’s some shushiness in the high end, too, that’s most apparent with cymbals. It’s not so much that listening for extended periods fatigues my ears, but it pulls my attention at times and can’t be fixed with the treble adjustment.
The Elite 5’s ANC is decent, but it doesn’t measure up to the competition.
Jabra’s noise canceling has always ranged from good to solid performance, especially for the price. A year ago I would have said the same about the Elite 5, but ANC performance from Jabra’s competitors has improved more than it has here, and extended into cheaper options. The Sony Linkbuds S addresses midrange and, to an extent, high-end suppression better than the Elite 5 for $50 more. And the Anker Soundcore Space A40 has slightly better low-end performance than the Elite 5 for $50 less.
That isn’t to say the Elite 5 doesn’t do the job. Their low-end cancelation is decent, but an airplane drone is still perceptible. The conversation also breaks through and they have a subtle but distinct high-level hiss.
The Jabra Elite 5 are feature-laden earbuds that aim to be the go-to for multiple applications, and to an extent, they succeed. If you accept their average audio performance, they serve well as an all-around pair of earbuds thanks to their feature customization, above-average IP rating, good call performance, and long battery life.
There are definitely earbuds that excel where the Elite 5 stumble. The Sony Linkbuds S retail for $50 more (although it can be regularly found for the same price as the Elite 5) but have better ANC performance and the Sony Headphones app allow you to really dial in excellent sound quality. And the new Anker Soundcore Space A40 comes in at just under $100 and equal the ANC performance of the Jabra.
If you’re looking for customizable earbuds that can transition from taking calls at the office to a quick workout at the gym before a walk home, the Jabra Elite 5 has got you covered.
The product experts at Reviewed have all your shopping needs covered. Follow Reviewed on Facebook, Twitter, Instagram, TikTok, or Flipboard for the latest deals, product reviews, and more.
Prices were accurate at the time this article was published but may change over time.
John Higgins
Editor, Electronics & Audio/Video
John is the A/V Editor for Reviewed. He is an ISF Level III-certified calibrator with bylines at ProjectorCentral, Wirecutter, IGN, Home Theater Review, T3, Sound & Vision, and Home Theater Magazine. When away from the Reviewed office, he is a sound editor for film and musician, and loves to play games with his son.
Our team is here for one purpose: to help you buy the best stuff and love what you own. Our writers, editors, and lab technicians obsess over the products we cover to make sure you’re confident and satisfied. Have a different opinion about something we recommend? Email us and we’ll compare notes.
Enter your email:
This site is protected by reCAPTCHA. The Google Privacy Policy and Terms of Service apply.
©2022 Reviewed, a division of Gannett Satellite Information Network LLC. All rights reserved.

Recommendations are independently chosen by Reviewed’s editors. Purchases you make through our links may earn us a commission.
Enter your email:
This site is protected by reCAPTCHA. The Google Privacy Policy and Terms of Service apply.

source

4 Video Editing Apps like PRISM Live Studio – Techiexpert.com – TechiExpert.com

Video editing has become an integral part of our lives. It would not be easy to imagine a presence on social media platforms without video editing apps. Hence, it is essential to have the best video editing apps. However, the pioneer of video editing apps is PRISM Live Studio. It has some of the best features that would be difficult to find in ordinary video editing apps. However, it could not be feasible for some users to use PRISM Live Studio. Thus, it’s always better to have alternatives in mind. We have listed down the top 5 Video Editing Apps Like PRISM Live Studio.
If one has to name a perfect live streaming software, it must be the Steamlabs Desktop. It is one of the most popular streaming software in the market. The app’s main feature is that it allows users to broadcast their live streams on various video platforms such as Twitter, Youtube, or Facebook. The Stremlabs can also be used as a video editing tool. It has a highlighter tool for streamers that offers an easy way to edit and create highlight videos from stream replays.
When there was no concept of screencasting, the VokoscreenNG had come up with the perfect software to make sure you look cool in front of your friends. If you are using Linux OS, then the tool is entirely free. Also, it is considered one of the best screencasting tools for Linux users. The app provides standard features you would expect in an ordinary screen recording tool. However, the USP of this software is its free version. The tool allows you to record the entire desktop. Apart from that, you can always record a particular area or a specific application window.
If you are a Youtuber or follow any gamer, you must have heard about OBS Studio in their conversations. OBS is free and open-source software for video recording and live streaming. Downloading and starting a stream on Windows, Mac, and Linux is easy through OBS Studio. Some of the features of OBS studio are High-performance real-time video/audio capturing and mixing, an unlimited number of scenes you can switch, an Intuitive audio mixer with per-source filters, Powerful and easy-to-use configuration options, access to a wide array of configuration options, and a Modular’ Dock’. All these features make OBS Studio one of the perfect video streaming platforms.
When it comes to professional video streaming platforms, then it would be unfair to overlook the Restream. With this app, one can easily create and broadcast live streams from your browser to 30+ social platforms, including Facebook, YouTube, LinkedIn, and more. Most of the users have termed it as a hassle-free video streaming platform. Apart from that, their analytics says that Restream is the most popular platform for businesses, entrepreneurs, content creators, social community managers, influencers, and gamers to simultaneously stream live to multiple platforms.
There are tons of video streaming platforms in the market. However, it would help if you chose the software according to your preference. There are various tools for various purposes. Hence, make sure you shortlist your objectives and goals and choose the best one among the video mentioned above, editing apps like PRISM Live Studio.
© 2022 All Rights Reserved
© 2022 All Rights Reserved
Login to your account below




Fill the forms below to register



Please enter your username or email address to reset your password.

source

Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis | Communications Biology – Nature.com

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Communications Biology volume 5, Article number: 895 (2022)
Metrics details
Glioblastoma (GBM) is the most aggressive primary brain tumour for which both effective treatments and efficient tools for an early-stage diagnosis are lacking. Herein, we present curcumin-based fluorescent probes that are able to bind to aldehyde dehydrogenase 1A3 (ALDH1A3), an enzyme overexpressed in glioma stem cells (GSCs) and associated with stemness and invasiveness of GBM. Two compounds are selective versus ALDH1A3, without showing any appreciable interaction with other ALDH1A isoenzymes. Indeed, their fluorescent signal is detectable only in our positive controls in vitro and absent in cells that lack ALDH1A3. Remarkably, in vivo, our Probe selectively accumulate in glioblastoma cells, allowing the identification of the growing tumour mass. The significant specificity of our compounds is the necessary premise for their further development into glioblastoma cells detecting probes to be possibly used during neurosurgical operations.
The term Glioma refers to a class of primary brain tumors that represent the 40% of all brain tumors. Glioblastomas are characterized by highly morphological heterogeneous neoplasms. The term “Glioblastoma” is a synonym of grade IV astrocytoma (GBM multiforme, or conventional GBM accordingly to WHO classification). Two histologic variants of GBM has been recognized with different clinicopathologic properties: gliosarcoma and giant cell glioblastoma1. Moreover, transcriptomic profiling has permitted to divide GBMs in four significant subtypes: proneural (PN), neural, classic, and mesenchymal (Mes)2,3. GBMs are very invasive and associated with a high ability to metastasize, with an extremely fast cell growth, a marked chemoresistance and a poor clinical outcome4. Their marked drug resistance is related to the presence of a high density of cancer stem cells (CSCs) that possess self-renewal ability and an unlimited proliferative potential, just like their physiological counterparts5,6. Glioma stem cells (GSCs) also provide the tumor with an enhanced resistance to drugs, radiation and oxidative stress, thus increasing GBM resistance to treatments, and their presence is associated with metastasis and relapse. Moreover, mesenchymal GSCs (Mes-GSCs) proved to be significantly more radioresistant than proneural GSCs (PN-GSCs)7,8,9,10. It has been demonstrated that the radiation treatment can induce the phenotype shift from PN to Mes, set out by the loss of the PN marker SOX2 and by the expression of the Mes marker CD4411. The tumors that are rich in Mes GSCs are the deadliest, the most dangerous and the most susceptible to relapse. As far as the tumorigenic behavior is concerned, Mes-GSCs showcased a higher growth potential under identical conditions compared to PN-GSCs both in vitro and in vivo2. The only resolutive treatment is the surgery that, when possible, allows the complete resection of the main tumor12,13. Even with this approach, though, the patient lifespan is around 5 years. This is the reason why the development of innovative tools for an early diagnosis and for the chemo treatment is of the utmost importance. In a paper published by Zhang et al.14, a transcriptomic analysis highlights the enrichment of the cytoplasmatic enzyme aldehyde dehydrogenase 1A3 (ALDH1A3) in Mes-GSCs. ALDH1A3 belongs to an enzymatic superfamily of aldehyde dehydrogenases, composed of 19 different isoforms, and involved in the irreversible NAD+-dependent oxidation of a wide range of aldehydes15. This superfamily is also involved in the reduction of oxidative stress and in the metabolism of several drugs, such as cyclophosphamide16. ALDH1A3 belongs to the ALDH1A superfamily, that also includes ALDH1A1 and ALDH1A2. All three isoenzymes are involved in the oxidation of retinal to retinoic acid, a molecule that is essential for tissue differentiation and cellular development17,18. ALDH1A1 and ALDH1A3 have been described as important markers19,20 and targets21,22,23 of CSCs in a wide variety of tumors. A several number of evidence acknowledge that ALDH1A3 can be considered a characteristic hallmark of the Mes-GSCs, which may play an important role in glioma malignancy, given that it is involved in stem cell viability drug resistance and cells maintenance arguing tumor invasion24,25. Considering the well-known catalytic function of ALDHs, they are regarded as the key enzymes that can detoxify harmful aldehydes within the organism, and this could be the reason why so many cytotoxic antineoplastic molecules are inactivated by CSCs26,27,28. As a result, ALDH1A1 and ALDH1A3 may protect CSCs from antineoplastic molecules, their levels could represent a prognostic factor that could anticipate the chemotherapy efficacy and their inhibition could make the tumor cells susceptible to medical treatments29,30,31. To date, CSCs are considered as one of the key mechanisms used by the tumor to evade chemotherapy and radiation treatment. Based on these evidences targeting CSCs aiming to improve already-existing therapies, prevent the relapse of the tumor and facilitate an early diagnosis could improve already-existing therapies and prevent the relapse of the tumor.
Curcumin is the most famous and most abundant congener of curcuminoids, a class of bioactive compounds isolated from turmeric (Curcuma longa L.) and commonly used for flavoring food in the Southeast Asian and Middle Eastern countries. Nowadays it is used in the food industry as a coloring agent known as E100. In the past decade, this natural dye became one of the best candidates for the development of new therapies against gliomas32. The antineoplastic abilities of curcumin, such as the induction of apoptosis and the inhibition of proliferation and invasion, have been proved in several tumors, including gliomas. Curcumin is also capable of inducing reactive oxygen species (ROS) in a wide variety of cancers, so as to lead to the activation of the MAPK apoptotic pathway33. Even though CSCs radical scavenging systems have been reported, several studies confirmed that curcumin-induced ROS can target GSCs34. However, this plethora of bioactivities should be viewed with skepticism: curcumin is one of the most famous Pan-Assay Interference Compounds, exhibiting all known behaviors of this class of molecules and confining it to a mere academic curiosity35. Besides the well-known health-promoting benefits, curcumin also possesses a strong intrinsic fluorescence and some of its derivatives have recently been acknowledged as optical probes for the in vivo studies of several diseases, such as Alzheimer36 and solid tumor37,38.
To date, as the surgical resection of the tumor mass is the fundamental treatment for GBM, having a tool that could lead to an early diagnosis and improve the surgeon accuracy during the operation would be a great advantage39. Therefore, a fluorescent probe that can detect a mass of CSCs within the brain of a patient with glioma could be extremely helpful and useful. In this paper, we present the first study of two different selective ALDH1A3 fluorescent probes, with a curcumin scaffold-based nature, that are able to inhibit the activity of the recombinant enzyme and can be detectable only in our positive controls, both in vitro and in vivo.
In this project we propose the synthesis of a class of curcumin-based probes where a triazole moiety is used as connector between the fluorescent dye and the functional group needed for the interaction with the active site of the enzyme. Since we already worked on the curcumin scaffold40,41,42,43, we identified five key synthons as starting points: the hemi-curcuminoids 4 and 5, the O-propargyl-vanillin (3) and the azido derivatives 8 and 9. Compounds 4 and 5 were easily obtained condensing respectively vanillin (1) and 4-(dimethylamino)benzaldehyde (2) with acetylacetone under Pabon conditions44. The replacement of the vanillic moiety with a dimetylamino group was done to modulate the fluorescence emission45 and, in the attempt to enhance the solubility of the final compound. A second Pabon condensation of hemi-curcuminoids 4 and 5 with O-propargyl-vanillin (3), furnished respectively compounds 6 and 7 that underwent to a copper catalyzed Huisgen [3 + 2] cycloaddition with 8 and 9 leading compounds 10, 11 and 12. Given the possible solubility problems due to the presence of a triazole moiety together with a curcuminoid sub-structure46,47, compounds 10 and 11 were phosphorylated using diethylchlorophosphate in presence of triethylamine affording compounds 13 and 14 (Fig. 1 and Supplementary Fig. S1).
(I) Acetylacetone, boron oxide, trimethyl borate, n-butylamine, DMF; (II) acetylacetone, boron oxide, trimethyl borate, n-butylamine, EtOAc; (III) boron oxide, trimethyl borate, n-butylamine, DMF; (IV) CuSO4, Na-ascorbate, t-BuOH/H2O/CH3CN 2:1:1; (V) CuSO4, Na-ascorbate, t-BuOH/H2O/CH3CN 2:1:1; (VI) diethylchlorophosphate, TEA, CH2Cl2.
All five fluorescent compounds were firstly characterized for their solubility in physiological buffer and for their absorbance values. We then performed a 3D analysis using a TECAN SPARK to simultaneously evaluate the excitation and the emission wavelengths, that were supposed to be similar to the curcumin ones48. Among all five molecules, the Probe 10 and 11 showed the highest solubility and their fluorescence values were similar to the not substituted fluorophore. For these reasons, we decided to continue the biochemical characterization on Probe 10 and 11 using the selected parameters (Fig. 2). The fluorescent signal changes for both molecules upon binding to the target, were firstly evaluated with recombinant human ALDH1A3. Prior to the interaction with the target protein, the two probes possess an intrinsic low fluorescence emission, but the subsequent addition of ALDH1A3 to the mix leads to a consistent increase in the intensity of the fluorescent signal of about 12 folds for Probe 10 and 8 folds for Probe 11 (Fig. 2). To better characterized our fluorescent compounds, we tested their potential cross-reactivity toward the other two isoforms of the ALDH1A subfamily. As shown in Fig. 2, Probe 10 exhibits low cross-reactivity with the other two isoforms, with a reduction of the fluorescence signal of about 2 folds for ALDH1A1 and 4 folds for ALDH1A2, compared to what observed with ALDH1A3. In the case of probe 11, 4 folds and 6 folds reduction of fluorescence was observed in the presence of ALDH1A1 and ALDH1A2, respectively, compared to what observed with ALDH1A3. Both probes therefore revealed selectivity for ALDH1A3. In addition, a wide range of biologically relevant analytes were tested at a concentration of 100 μM in complex with a fixed concentration of 10 μM of the probe (either probe 10 or probe 11), to make sure that no potential off-target signals could affect the analysis. More specifically, we checked if there were abnormal fluorescence signals that could have been contributed by the presence of biologically relevant compounds, (e.g., biologically relevant amino acids), to buffers and molecules commonly used in experimental procedures. None of the selected compounds generated significant fluorescent signals, compared with the positive controls (Fig. 2).
a Increase of Probe 10 fluorescence intensity in presence of various biomolecules reactive at concentrations of 100 μM. For all assays, Probe 10 was used at 10 μM final concentration and valuation of the absorbance, excitation and emission wavelengths of the compound Probe 10 at a fixed concentration of 10 µM in the SEC buffer. b Increase of Probe 11 fluorescence intensity in presence of various biomolecules reactive at concentrations of 100 μM and evaluation of the absorbance, excitation, and emission wavelengths of the compound Probe 11 at a fixed concentration of 10 µM in the SEC buffer.
On the basis of these encouraging results, we conducted an in-depth biochemical analysis on the two probes in order to characterize their mechanism of action. For greater clarity we will first illustrate the results obtained for Probe 10 and then those for Probe 11. The affinity of Probe 10 to the different isoenzymes revealed highly similar Kd values for all the three forms (ALDH1A1 = 31.1 μM R2 = 0.98, ALDH1A2 = 36.9 μM R2 = 0.98 and ALDH1A3 = 38.2 μM R2 = 0.96). To clearly understand the nature of the interaction between Probe 10 and ALDH1A3 we tested our fluorescent compound as an inhibitor, using an already published protocol17. As shown in Fig. 3a, ALDH1A3 resulted to be the only strongly inhibited isozyme, with a Ki value of 0.880 μM (R2 = 0.97) and a competitive mechanism of action. Neither of the two other isozymes were inhibited, even at the highest probe concentration used to test the catalytic activities of ALDH1A1 and ALDH1A2. Probe 10 was also tested as a possible substrate, due to the presence of a benzaldehyde on the lateral chain of the fluorophore (Fig. 3b). Indeed, after 1 h of incubation, Probe 10 was fully metabolized and converted to its carboxylic derivative (Probe 10-COOH) by both ALDH1A1 and in part by ALDH1A2, while no oxidation could be detected in the case of ALDH1A3 as unambiguously demonstrated by a LC-HRMS analysis (Fig. 4 and Supplementary Fig. S2.a). Our investigations clearly demonstrate that Probe 10 binds to the enzyme active site without undergoing oxidation. All the results obtained allow us to understand and explain why it shows the same affinity toward the three isoenzymes: it is a substrate for ALDH1A1 and ALDH1A2 and a potent competitive inhibitor for the isoform 1A3. In conclusion, the isoform 1A3 is inhibited by Probe 10 in the low micromolar range, shows selectivity vs. the other two isoforms and its binding to the enzyme active site results in a significant increase of the fluorescence signal.
a KM graph and value of the complex between Probe 10 at fixed concentration and various concentration of ALDH1A1 and ALDH1A2. b Ki graph and value of the complex between Probe 10 and ALDH1A3, in presence of different substrate and probe concentration. Probe 10 was analyzed as potential full competitive inhibitor.
LC-HRMS results after 1 h of incubation of single isoenzyme with Probe 10 in presence of ALDH1A1, ALDH1A2 and ALDH1A3. It is possible to appreciate the formation of the corresponding acid (Probe 10-COOH) for 1A1 and 1A2 but not for ALDH1A3. (TIC total ion current).
As described above for molecule 10, the affinity of Probe 11 for the three isozymes has also been investigated by determining the Kd of the compound-enzyme complexes. Probe 11 preferentially interacts with ALDH1A1 and ALDH1A3, with similar Kd values, while is less affine to the ALDH1A2 isoform (Supplementary Fig. S3). Surprisingly, Probe 11 has no inhibitory effect against any of the three ALDH1A isoenzymes and has not been shown to be a substrate. These results have been further confirmed by LC-HRMS experiments carried out on Probe 11 in the presence of the three different isoenzymes (Supplementary Fig. S2.b). Overall, our data suggest that Probe 11 does not display a strong selectivity among the three enzymes but rather behaves as a pan-probe for the ALDH1A subfamily.
Taken together, and from a biochemical perspective, these results suggest that both compounds are suitable for our aims with Probe 10 that emerges as the best performer. Yet, a much deeper in vitro analysis is needed to confirm the potential selectivity of Probe 10 and Probe 11 and to better investigate the possible cytotoxic effects.
To better characterized the selectivity fluorescence profile of Probe 10, we selected four cell lines based on their different ALDH1As expression profile, as described in The Human Protein Atlas (https://www.proteinatlas.org/), in order to validate the in vitro behavior of the two probes. Human U87MG glioblastoma cells are labeled as ALDH1A3+ cell line, HEK293T as ALDH1A2+ cell line, human fetal astrocytes (hASTRO) as ALDH1A1+ cell line and 4T1 mammary carcinoma as triple negative ALDH1As subfamily23. Moreover, we have chosen two different patient-derived glioblastoma cell lines (3054 and 3060) according to their increased expression levels of ALDH1A3 compared to the other ALDH1A isoforms (ALDH1A3 fold change of 8.58 and 7.34, ALDH1A2 fold change 5.8 and 5.6, ALDH1A1 4.1 and 4.5, respectively, as reported in HGCC site https://www.hgcc.se/). We determined the ability of Probe 10 to enter the cells and verified its fluorescence in ALDH1A3 positive cells. As depicted in Fig. 5a, b, Probe 10 can determine fluorescence in patient-derived glioblastoma cell lines 3054, 3060 and in the immortalized line U87MG, but not in HEK293T, hASTRO and 4T1 cell lines (Fig. 5c–e). The probe is localized to the cytoplasm confirming the specific and exclusively cytosolic binding to ALDH1A3, as confirmed with fluorescence quantification (Fig. 5g). At the same time, Probe 10 is unable to induce cell mortality (Fig. 6a). These data were corroborated by the results of flow cytometry analysis (Fig. 6b–d and Supplementary Fig. S4), showing that positivity to Probe 10 was limited to ALDH1A3+ cells. Positivity reverted with pre-treatment by the pan-ALDH inhibitor DEAB. Moreover, the fluorescence has been observed using Probe 11 only in U87MG cell lines (Supplementary Fig. S5a–d).
Fluorescence microscope images for Probe 10 detection in a patient-derived glioma cell 3054, b 3060, c U87MG, d 4T1, e HEK293T and f normal hASTRO at 10 µM, after 2 h of incubation. g Relative fluorescence intensity of the images acquired. ****p value <0.001.
a Cell viability at 10 µM of Probe 10 at 72 h. Flow cytometry analysis of b 3054, c 3060, d U87-MG cells unstained, stained with Probe 11 (10 µM) with or without DEAB (1 µM). On the right of each panel of flow cytometry histographic profiles of unstained, stained with Probe 10 (10 µM) with or without DEAB (1 µM) is reported.
Based on the excellent results obtained from the in vitro analyses, we decided to verify the potential of our probes also in vivo. The presence of a mouse ortholog of our target enzyme, ALDH1A3, having a sequence homology equal to 98%, allowed us to set up an in vivo experiment. To evaluate the fluorescent signal of both probes in an in vivo model of orthotopic transplantation of glioblastoma cells, we decided to use the GL261, a murine transplantable high grade glioma cell line positive to ALDH1A3. We initially measured the mRNA of the enzyme of our interest and checked whether the GL261 cells show the same permeability to our fluorescent compounds (Fig. 7a and Supplementary Fig. S6). Figure 7b, c and Supplementary Fig. S6 show that also in GL261 cells both Probes 10 and 11 were able to enter and label the murine glioblastoma cells. In particular, Probe 11 in vitro displays a higher intrinsic fluorescence, but it is less selective due to the presence of background signals that are non-specific for cancer cells internalization, as already suggested by the biochemical experiments. Nevertheless, even if the fluorescent signal has turned out to be lower in vitro, Probe 10 appears to be more promising, due to its ability to accumulate in tumor cells with a lower background signal. Subsequently, we induced glioblastoma in mice brain by stereotactically injecting 1 × 105 GL261 cells into the left striatum of adult mice. All mice were injected i.p. with an equivalent dose of the 2 probes. The in vivo experiments showed that only Probe 10 was able to selectively label the growing tumor. As shown in Fig. 8a–c, Probe 10 accumulates in GL261 cells outlining the tumor growing in the left striatum and invading the adjacent areas of the brain, without significant interference from the adjacent tissue. Scattered tumor cells were also visualized infiltrating the adjacent areas of the mouse brain. In addition, it is possible to appreciate that in tumor the fluorescence of Probe 10 is mostly contained in the cytoplasm of cancer cells (Fig. 8d–f). The same coronal section of a tumor-bearing brain in an animal injected with compound Probe 11 does not penetrate to any appreciable level the tumor cells in vivo, despite penetrating GL261 cells in vitro (Fig. 8g–i).
a Results of quantitative rtPCR showing the levels of expression of ALDH1A1 (1a1), ALDH1A2 (1a2) and ALDH1A3 (1a3) in murine GL261 cells. ALDH1A3 is significantly more expressed than the other isoforms. b Living GL261 cells were analyzed through an ImageStreamX MarkII using two channels: brightfield (Ch 01) and fluorescence (Ch 02) after 1 h incubation in probe 10, cells were thoroughly washed in PBS and analyzed. Two different representative cells are shown. From above, row 1 brightfield images (Ch 01), row 2 fluorescent images (Ch 02). “In Focus Cells” were identified based on the “Gradient Root Mean Square (RMS) Contrast Feature” that captures in focus images of cells identified by high normalized pixel intensity gradient (RMS values) derived from Ch 01; then, a scatter plot of the “Aspect Ratio Feature” vs. brightfield “Area Feature” was used to identify single cells (singlets) from debris or cell clumps based on high aspect ratio and low area value. c Fluorescence intensity variations are shown in the histogram and dot plot (Area vs. Intensity). Scale bars: 5 µm are the same in all images.
a–f Confocal images showing the same coronal section of a tumor-bearing brain in an animal. injected i.p. with Probe 10 for 6 h. In all images the area boxed is the same and it is shown at higher magnification in d–f. In a cell nuclei are stained by DAPI, in 6b, GL261 cells containing Probe 10 fluorescence in green. Most of the fluorescence comes from glioma cells growing in the left striatum and adjacent structures that have taken up and metabolized Probe 10. Scale bars: 25 μM. In 6c, the image shows the double fluorescence of DAPI and Probe 10 together. d–f show confocal images showing at higher magnification the area boxed in 6a–c. Fluorescence of Probe 10 is mostly contained in the cytoplasm. Scale bars: 25 μM. g–h Confocal images showing, under different fluorescence conditions, the same coronal section of a tumor-bearing brain in an animal i.p. injected with compound Probe 11 that does not penetrate to any appreciable level the tumor cells in vivo, despite penetrating GL261 cells in vitro. Scale bars: 25 μM. i Confocal image under excitation and filtering conditions appropriate both for DAPI and Probe 11, no fluorescence due to Probe 11 is visible despite the abundance of tumor cells.
The research of new targets for anti-cancer therapies and of markers for an efficient surgery and diagnosis still represents an ongoing challenge for several tumors and in particular for glioblastoma. With this paper, we describe new possible selective probes that are able to detect ALDH1A3 in GBM cancer cells. Both fluorescent compounds showed biological interesting data, highlighting Probe 10 as a promising starting point the development of ALDH1As probes. Indeed, this molecule can be considered as the first selective fluorescent probe for human ALDH1A3 ever reported and characterized in a specific cancer cell line. The biochemical characterization of Probe 10 demonstrates its selectivity toward ALDH1A3, and our in vitro experiments confirmed a strong signal not only in U87 cell line, ALDH1A3+, but also in the patient-derived glioblastoma cell lines 3054 and 3060, compared with our negative controls where no significant emission was observed, meaning while, the in vitro imaging using the 4T1 cell line, ALDH1A−, but ALDHs positive, shows only unspecific signals. Moreover, fluorescence emission in ALDH1A3+ glioblastoma cell lines is only present in the cytosol, while the nucleus appeared unstained. Probe 10 is characterized by a benzaldehyde moiety on the lateral chain that is also present in DEAB49. Based on this chemical feature, Probe 10 showed a marked binding preference for ALDH1As, with highly similar KD values. Our biochemical data confirmed that Probe 10 binds to the catalytic site of all three isoenzyme and it is metabolized in its corresponding acidic form by ALDH1A1 and ALDH1A2 but not by ALDH1A3. In the latter, Probe 10 was observed to behave as a strong competitive inhibitor with Ki value in the low micromolar range (0.880 μM). As confirmed by the in vitro imaging analysis, Probe 10 was detectable only in our positive controls U87MG, 3054 and 3060, whereas in the negative controls we were not able to detect any significant cytosolic emission. As a result, the Probe 10 displays the characteristics of an inhibitor of ALDH1A3 that most probably directly interact with the catalytic cysteine, Cys 314, while the other two isoenzymes metabolize the molecule in a faster way. We also performed a flow cytometry analysis that showed that Probe 10 is more selective than Probe 11 on the U87 ALDH1A3+ cells, even with a lower fluorescent intensity. As show in result section, we confirmed our data also in vivo on model of orthotopic transplantation of GL261 glioblastoma cells, positive at the ortholog of human ALDH1A3. Our results clearly show that Probe 10 is able to delimit the cancerous mass. Indeed, we obtained a significant signal only delimited on the tumor tissue in treated animals. This property could be exploited to improve precision in fluorescence-guided resection of malignant gliomas. This is a rapidly evolving technique that is currently based on the injection of fluorescent markers like fluorescein and 5-aminolevulinic acid that accumulate in the tumor by unspecific mechanisms50,51,52. The finding of new markers, with the aim of designing more specific molecules for more effective therapies and faster diagnosis, is essential for the modern precision medicine and ALDH1A3 represents one of the most suitable candidates for this goal. Taken together, our results highlight that Probe 10 is a promising tool to selectively sort glioblastoma infiltrating cells, if compared with the probes already available on the market, such as ALDEFLOUR.
In conclusion, our results demonstrate that Probe 10 is the first ALDH1A3 selective fluorescent tool that is able to preferentially bind to the target enzyme, without inducing significant cytotoxic effects, both in vitro, in human Glioblastoma cells U87MG, 3054, 3060 and in vitro and in vivo murine GL261 cells outlining the tumor growing in the left striatum and invading the adjacent areas of the brain.
NMR spectra were measured on Bruker Avance 400 MHz spectrometer. Chemical shifts were referenced to the residual solvent signal (CDCl3: δH = 7.21, δC = 77.0). MS spectra were acquired by Thermo Scientific Q-Exactive Plus (Supporting Information S1). Reactions were monitored by thin-layer chromatography on Merck 60 F254 (0.25 mm) plates, visualized by staining with 5% H2SO4 in EtOH and heating. Organic phases were dried with Na2SO4 before evaporation. Chemical reagents and solvents were purchased from Sigma-Aldrich, TCI Europe or Fluorochem and were used without further purification unless stated otherwise. Petroleum ether with boiling point of 40–60 °C was used. Silica gel 60 (70–230 mesh) was used for gravity column chromatography.
Propargyl bromide (6.01 ml, 80% w/v in toluene, 52.580 mmol, 2 eq) was added to a suspension of vanillin (1, 4 g, 26.290 mmol, 1 eq) and potassium carbonate (5.09 g, 36.806 mmol, 1.4 eq) in acetone (80 ml). The suspension was heated to reflux for 12 h and the solvent was removed under reduced pressure. Water was added and the aqueous phase was extracted with EtOAc, washed with water, brine and dried. The crude was purified by column chromatography (PE/EtOAc 9:1 as eluent) to give 3-methoxy-4-propargyloxybenzaldehyde (3, 2.58 g, 52%) as white crystalline solid. 1H NMR (400 MHz, CDCl3) δ (400 MHz, CDCI3) 9.87 (s, 1H), 7.47 (dd, J1 = 6.8, J2 = 1.4 Hz, 1H), 7.44 (d, J = 1.4 Hz, 1H), 7.14 (d, J = 6.8 Hz, 1H), 4.86 (d, J = 2.5 Hz, 2H), 3.95 (s, 3H), 2.56 (t, J = 2.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 190.9, 152.1, 150.0, 130.9, 126.3, 112.5, 109.4, 77.4, 77.2, 56.6, 56.0; HRESIMS m/z [M + H]+ 191.0628 (calcd for C11H11O3, 191.0630).
Boron oxide (14.6 g, 174.85 mmol, 5.3 eq) and acetylacetone (13.5 ml, 131.46 mmol, 4 eq) were dissolved in DMF (10 ml) stirred at 80 °C for 1 h. The mixture was cooled to 0 °C, then trimethyl borate (23.8 ml, 209.55 mmol, 6.38 eq) and vanillin (1, 5 g, 32.86 mmol, 1 eq) were added. Butylamine (1.3 ml, 13.27 mmol, 0.4 eq) was then added dropwise. The obtained mixture was heated to 80 °C for 24 h, then cooled to room temperature and 5% AcOHaq (200 ml) was added. The suspension was then stirred for 2 h at room temperature and a yellow precipitate formed. The precipitate was filtered, washed with water (3 × 100 ml), and purified by chromatography over silica (PE/EtOAc 7:3) to afford (E)-6-(4-hydroxy-3-methoxyphenyl)hex-5-ene-2,4-dione (4, 3.22 g, 51%) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ (400 MHz, CDCI3) 7.53 (1H, d, J = 15.8 Hz, 1H), 7.09 (1H, dd, J = 8.2 Hz, J = 1.9 Hz, 1H), 7.02 (d, J = 1.9 Hz, 1H), 6.92 (d, J = 8.2 Hz, 1H), 6.32 (d, J = 15.8 Hz, 1H), 5.91 (1H, bs, OH), 5.62 (s, 1H), 3.94 (s, 3H), 2.16 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 197.0, 177.9, 147.7, 146.7, 140.0, 127.6, 122.6, 120.2, 114.8, 109.5, 100.7, 55.9, 26.5; HRESIMS m/z [M + H]+ 235.0973 (calcd for C13H15O4, 235.0970).
Boron oxide (4.17 g, 46.933 mmol, 0.4 eq) and 4-dimethylaminobenzaldehyde (2, 1 g, 6.705 mmol, 1 eq) were dissolved in EtOAc (50 ml) stirred at 80 °C for 1 h. The mixture was cooled to 0 °C, then trimethyl borate (761 ml, 6.705 mmol, 1 eq) and acetylacetone (6.88 ml, 67.047 mmol, 10 eq) were added. Butylamine (665 ml, 6.705 mmol, 1 eq) was then added dropwise. The obtained mixture was heated to 80 °C for 72 h, then cooled to room temperature. H2SO4 2 M (50 ml) was added, then the organic phase was washed with NaHCO3 s.s. (50 ml), water, brine and dried. The crude was purified by column chromatography (PE/EtOAc 9:1 as eluent) to afford 1-(4-(Dimethylamino)phenyl)-5-hydroxyhexa-1,4-dien-3-one (5, 291 mg, 19% yield) as a red powder. 1H NMR (400 MHz, CDCl3) δ 7.38 (s, 1H), 7.30 (d, J = 9.3 Hz, 2H), 6.64 (d, J = 9.3 Hz, 2H), 3.04 (s, 6H), 1.90 (d, J = 5.7 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 195.59, 179.56, 151.65, 140.98, 129.79, 122.79, 117.37, 111.92, 100.16, 40.11, 26.47; HRESIMS m/z [M + H]+ 232.1336 (calcd for C14H18NO2, 232.1338).
Boron oxide (142 mg, 1.708 mmol, 0.4 eq) and 4 (1 g, 4.269 mmol, 1 eq) were dissolved in DMF (2 ml) stirred at 80 °C for 1 h. The mixture was cooled to 0 °C, then trimethyl borate (810 ml, 7.129 mmol, 1.67 eq) and 3 (893 mg, 4.696 mmol, 1.1 eq) were added. Butylamine (7 ml, 0.071 mmol, 0.17 eq) was then added dropwise. The obtained mixture was heated to 80 °C for 24 h, then cooled to room temperature and 5% AcOHaq (50 ml) was added. The suspension was then stirred for 2 h at room temperature and an orange precipitate formed. The precipitate was filtered, washed with water (3 × 100 ml), and purified by chromatography over silica (PE/EtOAc 6:4) to afford (1E,4Z,6E)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(3-methoxy-4-(prop-2-yn-1-yloxy)phenyl)hepta-1,4,6-trien-3-one (6, 1.21 g, 72%) as an orange solid. 1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 15.7 Hz, 2H), 7.08–7.12 (m, 3H), 7.04 (s, 2H), 6.92 (d, J = 8.2 Hz, 1H), 6.45–6.51 (m, 2H), 5.81 (s, 1H), 4.79 (d, J = 2.3 Hz, 2H), 3.92 (d, J = 6.2 Hz, 6H), 2.53 (t, J = 4.84, 3H); 13C NMR (100 MHz, CDCl3) δ 183.72, 182.82, 149.75, 148.65, 148.01, 146.90, 140.81, 140.11, 129.23, 127.59, 122.95, 122.54, 122.06, 121.73, 114.93, 113.77, 110.44, 109.76, 101.39, 78.09, 76.30, 56.63, 55.99, 55.97; HRESIMS m/z [M + H]+ 407.1496 (calcd for C24H23O6, 407.1495).
Boron oxide (17 mg, 0.223 mmol, 0.4 eq) and 5 (130 mg, 0.558 mmol, 1 eq) were dissolved in EtOAc (3 ml) stirred at 80 °C for 1 h. The mixture was cooled to 0 °C, then trimethyl borate (191 ml, 0.949 mmol, 1.67 eq) and 3 (106, 0.558 mmol, 1 eq) were added. Butylamine (9 ml, 0.095 mmol, 0.17 eq) was then added dropwise. The obtained mixture was heated to 80 °C for 24 h, then cooled to room temperature. H2SO4 2 M (50 ml) was added, then the organic phase was washed with water, brine and dried. The crude was purified by column chromatography (PE/EtOAc 7:3 as eluent) to afford (1E,4Z,6E)-1-(4-(dimethylamino)phenyl)-5-hydroxy-7-(3-methoxy-4-(prop-2-yn-1-yloxy)phenyl)hepta-1,4,6-trien-3-one (7, 70 mg, 19% yield) as a red powder. 1H NMR (300 MHz, CDCl3) δ 7.63 (d, J = 15.8 Hz, 1H), 7.57 (d, J = 15.8 Hz, 1H), 7.46 (d, J = 8.9 Hz, 2H), 7.08 (m, 3H), 6.69 (d, J = 8.6 Hz, 2H), 6.50 (d, J = 15.8 Hz, 1H), 6.43 (d, J = 15.8 Hz, 1H), 5.78 (s, 1H), 4.80 (d, J = 2.4 Hz, 2H), 3.92 (s, 3H), 3.03 (s, 6H), 2.53 (t, J = 2.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 185.08, 181.34, 151.78, 149.75, 148.45, 141.69, 139.25, 131.06, 130.05, 129.48, 128.32, 127.23, 124.40, 123.80, 122.70, 121.90, 118.92, 117.97, 113.81, 111.91, 110.33, 101.26, 78.12, 76.24, 56.63, 55.93, 40.13; HRESIMS m/z [M + H]+ 404.1859 (calcd for C25H27NO4, 404.1862).
To a stirred solution of 4-hydroxybenzaldehyde (1 g, 8.188 mmol, 1 eq) in DMF (10 ml) K2CO3 (2.26 g, 16.376 mmol, 2 eq) and 2-bromoethanol (1.16 ml, 16.376 mmol, 2 eq) were added. The reaction was heated at 90 °C for 48 h, then cooled to room temperature. H2SO4 2 M (20 ml) was added, then the mixture was extracted with PE/Et2O 3:1 (50 ml) and the organic phase was washed with water, brine and dried. The crude was purified by column chromatography (PE/EtOAc 5:5 as eluent) to afford 4-(2-Hydroxyethoxy)benzaldehyde (1.36 g, 100%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 9.90 (s, 1H), 7.85 (d, J = 9.3 Hz, 2H), 7.03 (d, J = 8.7 Hz, 2H), 4.18 (t, J = 9.0 Hz, 2H), 4.02 (q, J = 9.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 191.07, 163.81, 132.07, 130.05, 114.89, 114.85, 69.62, 61.04; HRESIMS m/z [M + H]+ 166.0705 (calcd for C9H11O3, 166.0708).
A portion of the latter (680 mg, 4.094 mmol, 1 eq) was then dissolved in DCM (10 ml), then TEA (628 ml, 4.503 mmol, 1.1 eq) and methansulfonyl chloride (350 ml, 4.503 mmol, 1.1 eq) were added. The reaction was left at room temperature for 12 h, then quenched with H2SO4 2 M (20 ml). The organic phase was then washed with water, brine and dried. The crude was dissolved in DMF (10 ml), then sodium azide (798 mg, 12.382 mmol, 3 eq) and a catalytic amount of NaI were added. The reaction was heated at 65 °C for 12 h, then quenched with brine. The organic phase was dried, and the crude was purified by column chromatography (PE/EtOAc 5:5 as eluent) to afford 4-(2-Azidoethoxy)benzaldehyde (8, 712 mg, 91% over two steps) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ = 3.66 (t, J = 4.9 Hz, 2H), 4.23 (t, J = 4.9 Hz, 2H), 7.04 (d, J = 8.8 Hz, 2H), 7.85 (d, J = 8.8 Hz, 2H), 9.91 (s, 1H). 13C NMR (100 MHz, CDCl3) δ = 50.0, 67.2, 114.8, 130.5, 132.0, 163.1, 190.7; HRESIMS m/z [M + H]+ 192.0774 (calcd for C9H10N3O2, 192.0773).
To a stirred solution of ethyl 2-bromoacetate (11, 1 ml, 9.017 mmol, 1 eq) in DMF (10 ml), sodium azide (1.759 mg, 27.052 mmol, 3 eq) was added. The reaction was heated at 90 °C for 12 h, then quenched with brine and extracted with PE. The organic phase was dried, and concentration of the solvent under reduced pressure gave ethyl 2-azidoacetate (9, 1.16 g, 100%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 4.15 (q, J = 6.8 Hz, 2H), 3.77 (d, J = 1.2 Hz, 2H), 1.20 (td, J1 = 7.2, J2 = 1.2 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 168.1, 61.5, 50.0, 13.8; HRESIMS m/z [M + H]+ 130.0615 (calcd for C4H8N3O2, 130.0617).
To a stirred solution of 6 (50 mg, 0.123 mmol, 1 eq) in t-BuOH/H2O/CH3CN 2:1:1, 8 (56 mg, 0.256 mmol, 2 eq) and a catalytic amount of CuSO4 and sodium ascorbate were added. The solution was stirred at room temperature for 24 h, then diluted with brine and extracted with EtOAc. The organic phase was dried and evaporated, then the crude was purified by chromatography over silica gel (PE:EtOAc 3:7 as solvent) to afford 10 (32 mg, 30%) as an orange solid. Probes 11 and 12 were obtained following the same protocol.
10: orange powder, 30%. 1H NMR (400 MHz, CDCl3) δ = 9.91 (s, 1H), 7.87–7.83 (m, 3H), 7.63 (d, J = 10.4 Hz, 1H), 7.59 (d, J = 10.4 Hz, 1H), 7.16–7.07 (m, 4H), 6.98–6.92 (m, 3H), 6.51 (dd, J1 = 15.8 Hz, J2 = 2.9 Hz, 2H), 5.84 (s, 1H), 5.37 (s, 2H), 4.83 (t, J = 4.7 Hz, 2H), 4.48 (t, J = 4.7 Hz, 2H), 3.07 (s, 3H), 2.55 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 190.6, 183.6, 182.7, 162.5, 149.6, 149.3, 147.9, 146.8, 144.0, 140.7, 140.0, 132.0, 130.8, 128.9, 127.6, 124.3, 122.9, 122.5, 122.1, 121.7, 114.8, 114.7, 113.7, 110.4, 109.6, 101.3, 66.4, 62.8, 55.9, 49.7; HRESIMS m/z [M + H]+ 598.21869 (calcd for C33H32N3O8, 598.21839).
11: brown powder, 33%. 1H NMR (400 MHz, CDCl3) δ = 7.83 (s, 1H), 7.60 (dd, J1 = 15.7 Hz, J2 = 4.5 Hz, 2H), 7.14–7.07 (m, 4H), 6.95 (d, J = 8.2 Hz, 1H), 6.50 (dd, J1 = 15.7 Hz, J2 = 2.8 Hz, 2H), 5.83 (s, 1H), 5.38 (s, 2H), 5,17 (s, 2H), 4.28 (q, J = 7.1, 2H), 3.69 (s, 3H), 3.92 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 183.6, 182.9, 166.0, 149.6, 149.4, 147.9, 146.8, 144.2, 140.7, 140.1, 128.9, 127.6, 124.5, 124.5, 122.9, 122.4, 122.3, 121.7, 114.8, 113.8, 110.5, 109.6, 101.3, 62.8, 62.5, 55.9, 51.0, 14.0; HRESIMS m/z [M + H]+ 536.20245 (calcd for C28H30N3O8, 536.202741).
12: red powder, 31%. 1H NMR (400 MHz, CDCl3) δ = 9.91 (s, 1H), 7.84–7.86 (m, 2H), 7.67–7.58 (m, 3H), 7.20–7.03 (m, 3H), 6.97 (d, J = 8.7 Hz, 2H), 6.57 (d, J = 15.8 Hz, 2H), 6.52 (d, J = 15.8 Hz, 2H), 5.85 (s, 1H), 5.37 (s, 1H), 4.83 (t, J = 4.9 Hz, 2H), 4.48 (t, J = 4.9 Hz, 2H), 2.33 (s, 3H), 1.24 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 13C NMR (100 MHz, CDCl3) δ 190.6, 162.5, 149.6, 132.0, 130.8, 129.8, 124.2, 122.5, 114.7, 113.7, 110.4, 81.7, 66.4, 62.9, 56.0, 49.6, 29.7; HRESIMS m/z [M + H]+ 628.23096 (calcd for C34H35N4O6, 628.22896).
To stirred solution of 10 (150 mg, 0.251 mmol, 1 eq) in dry DCM (10 ml), TEA (105 ml, 0.753 mmol, 3 eq) and diethylchlorophosphate (54 ml, 0.377 mmol, 1.5 eq) were added. The reaction was stirred at room temperature for 24 h, then quenched with H2SO4 2 M. The organic phase was then washed with brine and dried. The crude was purified by chromatography over silica (EtOAC as eluent) to afford Probe 13 (47 mg, 23%) as orange solid. Probe 14 was obtained following the same protocol.
13: orange solid, 23%. 1H NMR (400 MHz, CDCl3) δ = 9.90 (s, 1H), 7.83–7.79 (m, 3H), 7.61 (d, J = 15.7 Hz, 2H), 7.35–6.95 (m, 7H), 6.54 (m, 2H), 5.86 (s, 1H), 5.37 (s, 2H), 4.83 (bt, 2H), 4.47 (bt, 2H), 4.30 (m, 4H) 3.95 (s, 3H), 3.93 (s, 3H), 1.39 (t, J = 6.89 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 190.6, 183.9, 182.3, 162.5, 150.9, 150.9, 149.6, 149.4, 143.9, 141.3, 140.5, 139.5, 132.8, 132.0, 130.7, 128.8, 124.3, 124.0, 122.5, 122.3, 121.6, 121.1, 114.7, 113.7, 111.7, 110.5, 101.6, 66.4, 64.7, 64.7, 62.8, 56.0, 49.7, 16.1, 16.0; HRESIMS m/z [M + H]+ 734.24738 (calcd for C37H41N3O11P, 734.24732).
14: brown solid, 76%. 1H NMR (400 MHz, CDCl3) δ 7.83 (s, 1H), 7.61 (d, J = 6.7 Hz, 1H), 7.57 (d, J = 6.7 Hz, 1H), 7.32 (d, J = 7.9 Hz, 1H),7.13–7.08 (m, 4H), 6.57–6.49 (m, 2H), 5.85 (s, 3H), 5.36 (s, 2H), 5.16 (s, 2H), 4.30–4.19 (m, 6H), 3.92 (s, 3H), 3.91 (s, 3H), 1.38 (t, J = 7.0 Hz, 3H). 1.30 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 184.0, 182.2, 166.0, 150.8, 149.7, 149.5, 144.1, 141.3, 140.6, 139.4, 132.8, 128.7, 124.6, 124.0, 122.3, 121.5, 121.0, 113.7, 111.7, 110.5, 101.6, 64.7, 62.8, 62.5, 56.0, 51.0, 29.7, 16.1, 14.0; HRESIMS m/z [M + H]+ 672.23120 (calcd for C32H39N3O11P, 672.23167).
To a stirred solution of 6 (50 mg, 0.123 mmol, 1 eq) in t-BuOH/H2O/CH3CN 2:1:1, 8 (56 mg, 0.256 mmol, 2 eq) and a catalytic amount of CuSO4 and sodium ascorbate were added. The solution was stirred at room temperature for 24 h, then diluted with brine and extracted with EtOAc. The organic phase was dried and evaporated, then the crude was purified by chromatography over silica gel (PE:EtOAc 3:7 as solvent) to afford 10 (32 mg, 30%) as an orange solid. Probes 11 and 12 were obtained following the same protocol.
10: orange powder, 30%. 1H NMR (400 MHz, CDCl3) δ = 9.91 (s, 1H), 7.87–7.83 (m, 3H), 7.63 (d, J = 10.4 Hz, 1H), 7.59 (d, J = 10.4 Hz, 1H), 7.16–7.07 (m, 4H), 6.98–6.92 (m, 3H), 6.51 (dd, J1 = 15.8 Hz, J2 = 2.9 Hz, 2H), 5.84 (s, 1H), 5.37 (s, 2H), 4.83 (t, J = 4.7 Hz, 2H), 4.48 (t, J = 4.7 Hz, 2H), 3.07 (s, 3H), 2.55 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 190.6, 183.6, 182.7, 162.5, 149.6, 149.3, 147.9, 146.8, 144.0, 140.7, 140.0, 132.0, 130.8, 128.9, 127.6, 124.3, 122.9, 122.5, 122.1, 121.7, 114.8, 114.7, 113.7, 110.4, 109.6, 101.3, 66.4, 62.8, 55.9, 49.7; HRESIMS m/z [M + H]+ 598.21869 (calcd for C33H32N3O8, 598.21839).
11: brown powder, 33%. 1H NMR (400 MHz, CDCl3) δ = 7.83 (s, 1H), 7.60 (dd, J1 = 15.7 Hz, J2 = 4.5 Hz, 2H), 7.14–7.07 (m, 4H), 6.95 (d, J = 8.2 Hz, 1H), 6.50 (dd, J1 = 15.7 Hz, J2 = 2.8 Hz, 2H), 5.83 (s, 1H), 5.38 (s, 2H), 5,17 (s, 2H), 4.28 (q, J = 7.1, 2H), 3.69 (s, 3H), 3.92 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 183.6, 182.9, 166.0, 149.6, 149.4, 147.9, 146.8, 144.2, 140.7, 140.1, 128.9, 127.6, 124.5, 124.5, 122.9, 122.4, 122.3, 121.7, 114.8, 113.8, 110.5, 109.6, 101.3, 62.8, 62.5, 55.9, 51.0, 14.0; HRESIMS m/z [M + H]+ 536.20245 (calcd for C28H30N3O8, 536.202741).
12: red powder, 31%. 1H NMR (400 MHz, CDCl3) δ = 9.91 (s, 1H), 7.84–7.86 (m, 2H), 7.67–7.58 (m, 3H), 7.20–7.03 (m, 3H), 6.97 (d, J = 8.7 Hz, 2H), 6.57 (d, J = 15.8 Hz, 2H), 6.52 (d, J = 15.8 Hz, 2H), 5.85 (s, 1H), 5.37 (s, 1H), 4.83 (t, J = 4.9 Hz, 2H), 4.48 (t, J = 4.9 Hz, 2H), 2.33 (s, 3H), 1.24 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 13C NMR (100 MHz, CDCl3) δ 190.6, 162.5, 149.6, 132.0, 130.8, 129.8, 124.2, 122.5, 114.7, 113.7, 110.4, 81.7, 66.4, 62.9, 56.0, 49.6, 29.7; HRESIMS m/z [M + H]+ 628.23096 (calcd for C34H35N4O6, 628.22896).
To stirred solution of 10 (150 mg, 0.251 mmol, 1 eq) in dry DCM (10 ml), TEA (105 ml, 0.753 mmol, 3 eq) and diethylchlorophosphate (54 ml, 0.377 mmol, 1.5 eq) were added. The reaction was stirred at room temperature for 24 h, then quenched with H2SO4 2 M. The organic phase was then washed with brine and dried. The crude was purified by chromatography over silica (EtOAC as eluent) to afford Probe 13 (47 mg, 23%) as orange solid. Probe 14 was obtained following the same protocol.
13: orange solid, 23%. 1H NMR (400 MHz, CDCl3) δ = 9.90 (s, 1H), 7.83–7.79 (m, 3H), 7.61 (d, J = 15.7 Hz, 2H), 7.35–6.95 (m, 7H), 6.54 (m, 2H), 5.86 (s, 1H), 5.37 (s, 2H), 4.83 (bt, 2H), 4.47 (bt, 2H), 4.30 (m, 4H) 3.95 (s, 3H), 3.93 (s, 3H), 1.39 (t, J = 6.89 Hz, 6H). 13C NMR (100 MHz, CDCl3) δ 190.6, 183.9, 182.3, 162.5, 150.9, 150.9, 149.6, 149.4, 143.9, 141.3, 140.5, 139.5, 132.8, 132.0, 130.7, 128.8, 124.3, 124.0, 122.5, 122.3, 121.6, 121.1, 114.7, 113.7, 111.7, 110.5, 101.6, 66.4, 64.7, 64.7, 62.8, 56.0, 49.7, 16.1, 16.0; HRESIMS m/z [M + H]+ 734.24738 (calcd for C37H41N3O11P, 734.24732).
14: brown solid, 76%. 1H NMR (400 MHz, CDCl3) δ 7.83 (s, 1H), 7.61 (d, J = 6.7 Hz, 1H), 7.57 (d, J = 6.7 Hz, 1H), 7.32 (d, J = 7.9 Hz, 1H), 7.13–7.08 (m, 4H), 6.57–6.49 (m, 2H), 5.85 (s, 3H), 5.36 (s, 2H), 5.16 (s, 2H), 4.30–4.19 (m, 6H), 3.92 (s, 3H), 3.91 (s, 3H), 1.38 (t, J = 7.0 Hz, 3H). 1.30 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 184.0, 182.2, 166.0, 150.8, 149.7, 149.5, 144.1, 141.3, 140.6, 139.4, 132.8, 128.7, 124.6, 124.0, 122.3, 121.5, 121.0, 113.7, 111.7, 110.5, 101.6, 64.7, 62.8, 62.5, 56.0, 51.0, 29.7, 16.1, 14.0; HRESIMS m/z [M + H]+ 672.23120 (calcd for C32H39N3O11P, 672.23167).
A common experimental protocol has been developed with the aim of obtaining pure human ALDH1A1, 1A2 and 1A3 at a high yield, as already described23. Briefly, E. coli BL21 (DE3) were transformed with the full-length expression vector of each isoform and seeded onto 2xTY agar plates containing 50 μg/ml ampicillin for ALDH1A1 and ALDH1A3 subtypes, and 50 μg/ml kanamycin for ALDH1A2. Petri plates were incubated for the overnight growth at 37 °C. The following day, colonies were scraped and used to inoculate 1 l of 2xTY liquid medium, which was previously added with 50 μg/ml ampicillin for ALDH1A1 and ALDH1A3, and 50 μg/ml kanamycin for ALDH1A2. Flasks were put under shaking at 37 °C and, once OD600 = 0.6–0.8 was reached, the temperature was shifted to 20 °C to induce the recombinant protein production. The induced cells were collected by centrifugation and stored at −80 °C. The harvested pellet was thawed and resuspended in lysis buffer (50 mM Na2HPO4, 300 mM NaCl, 1 mM β-mercaptoethanol, 20 mM imidazole, pH 7.5) with 1 μl per 80 ml of lysis buffer of benzonase nuclease (250 U/μl). E. coli BL21 (DE3) cells were disrupted using a French Press system, three times at 1.5 Kbar, adding 100 μl per 40 ml of lysis buffer of a Protease inhibitor cocktail from SIGMA. To obtain the clarified cell lysate, the cell debris was removed by centrifugation at 18,000 rpm for 50 min. The recombinant proteins were purified by a His-tag affinity chromatography followed by size-exclusion chromatography, using an AKTA FPLC system at 4 °C. To better evaluate the purity and homogeneity of the protein after each purification step, eluted fractions were analyzed by SDS-PAGE. The final protein concentration was determined through the Bradford protein assay. In the first purification step, the collected supernatant was loaded on a Qiagen Ni-NTA Superflow 5 ml cartridge that was previously equilibrated with 10 column volumes of lysis buffer. The Ni-NTA cartridge was washed with 15 column volumes of 50 mM Na2HPO4, 300 mM NaCl, 1 mM β-mercaptoethanol, 50 mM imidazole, pH 7.5, until the absorbance at 280 nm returned to the baseline. The recombinant hALDH1A was eluted with 50 mM Na2HPO4, 300 mM NaCl, 1 mM β-mercaptoethanol, 250 mM imidazole, pH 8, by applying a linear gradient in 10 column volumes. Eluted fractions were pooled and concentrated to 5 ml with Merck Millipore Amicon Ultra-15 30 kDa and loaded on a HiLoad 16/600 Superdex 200 pg column on AKTA FPLC system. Elution buffer contained 20 mM Tris HCl pH 8.0, 150 mM KCl, 1 mM β-mercaptoethanol, and a flow rate of 1 ml/min was applied. By means of this procedure, 20 mg of pure and active human ALDH1A1, ALDH1A2 and ALDH1A3 were obtained, stocked at −80° and later used for biochemical analysis.
Fluorescent compounds were analyzed on a Tecan Spark to evaluate the correct parameters to further set the biochemical characterizations. The absorbance was evaluated in a range from 300 to 700 nm, with a wavelength step size of 5 nm. Based on the absorbance values, we settled a 3D fluorescence emission scan to evaluate the excitation and emission peaks. The analysis was conducted using the same buffer mix, as already described. The excitation range was set between 390 and 450 nm for both molecules, with a step size of 5 nm. The emission range was set between 485 and 700 nm for both molecules, with a step size of 5 nm. All these characterizations were performed on a Tecan Spark using Greiner Bio-One 96-UV-Transparent Microplates and the tests were carried out using a total volume of 100 μl for each well.
Based on the values obtained by the 3D analysis, a wide series of biomolecules directly used in the biochemical experiment, both in vitro and in vivo, and listed in Table 1, were tested in complex with a fixed concentration of 10 μM of both probes, to measure any possible cross reaction signal.
To evaluate the Kd constant between the two probes and the isoenzymes ALDH1A1, ALDH1A2 and ALDH1A3A we performed a fluorescence emission assay. We used a Tecan Spark with Greiner Bio-One 96-UV-Transparent Microplates. A single reaction was performed in a total volume of 100 μl per well containing 20 mM Tris HCl pH 8.0, 1 mM β-mercaptoethanol, 150 mM KCl, 500 μM NAD+ and 10 μM fluorescent probe with a 5% DMSO final concentration, in the presence of different ALDH1As concentrations, from 100 μM to 1.1719 μM. Each reaction mix was preincubated for 10 min at 25 °C before the analysis. The obtained raw data were analyzed using GraphPad to calculate Kd values.
The catalytic activity of the ALDH1As isoenzymes in complex with probe 10 was tested on a Tecan Sunrise 96 Multiplate Reader with Greiner Bio-One 96-UV-Transparent Microplates. The analysis was performed in triplicate in a total volume of 100 μl per well containing 20 mM Tris HCl pH 8.0, 1 mM β-mercaptoethanol, 150 mM KCl, 500 μM NAD+, 1.41 μM DMSO, 2.8 μM hALDH1As and Probe 10 was tested as substrate at different concentrations, from 300 μM to 3.125 μM. Each reaction mix was preincubated for 10 min at 25 °C before the analysis. The catalytic activity was measured by monitoring the absorbance at 340 nm (εNADH = 6220 M−1 cm−1) for 12 h at 25 °C and the inhibitory parameters were calculated by processing the raw data on GraphPad.
Initially, the inhibitory activities of our fluorescent probes were screened at a fixed concentration of 50 μM using a Tecan Sunrise 96 Multiplate Reader with Greiner Bio-One 96-UV-Transparent Microplates. The analysis was performed in triplicate in a total volume of 100 μl per well containing 20 mM Tris HCl pH 8.0, 1 mM β-mercaptoethanol, 150 mM KCl, 500 μM NAD+, 1.41 μM DMSO, 2.8 μM hALDH1A and 20 mM acetaldehyde. Afterwards, the inhibitory potency of the fluorescent probes was further investigated, evaluating the IC50 parameter. The enzymatic inhibition assays were performed in triplicate in a total volume of 100 μl per well containing 20 mM Tris HCl pH 8.0, 1 mM β-mercaptoethanol, 150 mM KCl, 500 μM NAD+, 2.8 μM hALDH1A and 20 mM acetaldehyde in the presence of different probe concentrations, from 200 μM to 1.5625 μM. The DMSO final concentration allowed was up to 15%. Only for ALDH1A3 in complex with Probe 10, the Ki affinity parameter was calculated by performing the analysis in triplicate in a total volume of 100 μl per well containing 20 mM Tris HCl pH 8.0, 1 mM β-mercaptoethanol, 150 mM KCl, 500 μM NAD+ and 2.8 μM ALDH1As. Due to chemical nature of Probe 10 and Probe 11, we set up the enzymatic assay assuming a competitive inhibition using different compounds concentration, from 200 μM to 1 μM, and different acetaldehyde concentrations, from 20 mM to 2.5 mM. Each reaction mix was preincubated for 10 min at 25 °C before the analysis. The catalytic activity was measured by monitoring the absorbance at 340 nm (εNADH = 6220 M−1 cm−1) for 30 min at 25 °C and the inhibitory parameters were calculated by processing the raw data on SigmaPlot53.
These analyses were carried out by using UPLC-HRMS procedure with Vanquish UPLC system coupled to a Thermo Scientific Q-Exactive Plus, operating in negative electrospray ionization mode. The chromatographic separation was carried out using a Phenomenex Synergi 4 µ Polar-RP 80 A (150 × 2 mm) equipped with a Phenomenex Polar-RP (4 mm × 2 mm) security guard column. The mobile phase consisted of A: acetonitrile 0.1% formic acid and B: 0.1% formic acid. We used a linear elution gradient, starting from 80% of A to 5% A in 3 min, 3 min at 5% A, an equilibration of 4 min for a total run time of 10.00 min, at 300 µl/min flow rate. The autosampler temperature was set at 15 °C, the injection volume was 5 µl and column was maintained at 40 °C. The heated electrospray ionization source was used, with a spray voltage of 3200 kV, with a capillary temperature of 300 °C, a heater temperature of 350 °C, a sheat gas flow of 45 arbitrary units (AU), an auxiliary gas flow of 10 AU and a sweep gas flow of 0 AU. During the Parallel Reaction Monitoring acquisition in negative ion mode, the instrument operated at 17,500 resolution in presence of the inclusion list (m/z = 596.20384 and m/z = 612.19875 for Probe 10 and Probe 10-COOH respectively; m/z = 534.18819 and m/z = 506.156888 for Probe 11 and Probe 11-COOH respectively) with an automatic gain control target of 2 × 105 charges and a maximum injection time of 100 ms. Before injecting the samples, the blanks in the list were analyzed and every biological sample was analyzed in duplicate. The biological samples analyzed were as follow: (1) Enzymatic assay Buffer; (2) Enzymatic assay Buffer + NAD+; (3) Enzymatic assay Buffer + Probe 10 or Probe 11; (4) Enzymatic assay Buffer + ALDH1A1; (5) Enzymatic assay Buffer + ALDH1A2; (6) Enzymatic assay Buffer + ALDH1A3; (7) Enzymatic assay Buffer + ALDH1A1 + Probe 10 or Probe 11; (8) Enzymatic assay Buffer + ALDH1A2 + Probe 10 or Probe 11; (9) Enzymatic assay Buffer + ALDH1A3 + Probe 10 or Probe 11. All samples were diluted 1:1 with ACN, then 1:100 in ACN-Water 1:1 prior the LC-HRMS analysis.
U87MG human glioblastoma, and 4T1 murine mammary carcinoma cell lines were cultured in Minimum Essential Medium Eagle (Sigma-Aldrich). The HEK293T human embryonic kidney cell line and GL261 high grade glioma cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich). All these cell lines with the exception of GL261 were purchased from ATCC. Media were supplemented with 10% fetal bovine serum (Gibco), 2 mg/ml glutamine, 10 U/ml penicillin and 100 g/ml streptomycin (Sigma-Aldrich). Normal human fetal astrocytes were kindly provided by Eleonora Aronica’s lab in Amsterdam and cultured in DMEM + F10 medium. Cells were maintained in a controlled atmosphere of 5% CO2 with humidity at 37 °C. Cells were detached from plates by trypsin-EDTA (Sigma-Aldrich). Patient-derived glioblastoma cells (#3054 and #3060) were acquired from the Human Glioblastoma Cell Culture resource (www.hgcc.se) at the Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden and cultured as previously reported54. Briefly, cells were cultured in 1:1 DMEM/F12:Neurobasal, in presence of 100X of N2, 50X of B27 (Gibco, Thermo Fisher Scientific), 10 ng/ml human FGF2 and 10 ng/ml human EGF (PeproTech).
In total, 20,000 cells/ml of U87MG, HEK293T, hASTRO and 4T1 were seeded onto glass cover slips in 24-well plates. The cells incubated at 37 °C in a 5% CO2 atmosphere overnight. Cells were washed with 1 ml of PBS buffer two times, then a 10 μM solution of probes was added to each well for 2 h. For nuclei staining, 1 µg/ml of DAPI was added the last 15 min of treatment. The cover slips were removed and washed with PBS buffer, and fixed with 0.5 ml of 4% formaldehyde solution for 10 min. The cover slips were washed with 1 ml of PBS, then slides were prepared using Mounting Media (Merck Life Science). Fluorescence images were acquired using a Leica THUNDER Imager 3D Live Cell (Leica Microsystems, Wetzlar, Germany) microscope equipped with an S Fluor 40×/1.3 objective using the LAS X software.
U87MG, 3054, 3060, HEK293T, hASTRO and 4T1 cells were resuspended in PBS to a final concentration of 106 cells/ml. Each sample was then resuspended in probe 10 and probe 11 solutions (1 µM, in ALDEFLUOR assay buffer, STEMCELL). Triplicate samples were prepared for each dye. Cells were pre-treated with DEAB for 15 min and then incubated with the probes for 30 min at room temperature, with rocking to prevent cell clumping and ensure an even dye distribution. At the end of the incubation period, cells were harvested by centrifugation at 1000 rpm for 5 min at 4 °C. The probe solutions were removed and each sample was resuspended in the ALDEFLUOR assay buffer. The samples were immediately placed in ice until analysis. The samples were analyzed by a S3e Cell Sorter (Bio-Rad).
GL261 cells were incubated, with probe 10 or 11, for 1 h and after three rinses in PBS, cells were detached by trypsin treatment and visualized without fixation through a rMarkII flow cytometer (Amnis, Luminex Corporation, Austin, TX, USA) as previously described55. Data were collected using Inspire software (Amnis, version 2.0) with the following parameters: 10,000 images per sample, 488 nm laser (25 and 100 mW) to excite the probes, 785 nm laser used to provide a side scatter signal and measurement of SpeedBeads (Amnis, Luminex Corporation, Austin, TX, USA), 830 nm laser used for internal bead calibration of core flow speed and focus, ×60 objective, in low-speed flow. Data were further analyzed by Ideas software (Amnis, version 6.1).
In total, 10 × 105 U87MG human glioblastoma, patient-derived glioma cells 3054 and 3060, HEK293T human embryonic kidney, 4T1 murine mammary carcinoma, human fetal astrocytes cell lines were plated in their respective medium and treated for 72 h with our fluorescent probe 10 and 11, solubilized in DMSO in a final concentration of 10%. We treated controls with DMSO in the same final concentration and we compared the viability of each treatment to controls. The viability of cells was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium assay (MTT assay)23.
We used in vitro and in vivo cells from a mouse high grade glioma cell line, GL26156. Briefly, ten 2- to 3-month-old female C57BlC mice were stereotactically implanted under deep general anesthesia (isoflurane supplemented with nitrous oxide) with 1 × 105 GL261 glioblastoma cells. The cells were stereotactically inoculated through a burr hole by a Hamilton syringe into the left striatum (coordinates: 1 mm anteroposterior and 1 mm lateral from bregma, at a depth of 3 mm). All experimental procedures were conducted in accordance with the European Communities Council Directive of the 24th of November 1986 (86/609 EEC), with the Recommendation 18/06/2007, Dir. 2010/63/UE and with the Italian law for care and use of experimental animals (DL116/92) and were approved by the Italian Ministry of Health (prot. E669C.15) and by the Bioethical Committee of the University of Turin. All animals were housed under a 12-h light-dark cycle in an environmentally controlled room. All experiments were designed to minimize the numbers of animals used and their discomfort. In each experiment, animals with tumors were allocated to two groups and i.p. injected with probe 10 (18 μg) or probe 11 (5 μg). All drugs were administered intraperitoneally 6 days after tumor implantation and the animals were euthanized under deep anesthesia 6 h after the i.p. injection of the probes. Briefly, they were transcardially perfused under deep anesthesia (ketamine 100 mg/mg, Ketavet, Bayern, Leverkusen, Germany; xylazine 5 mg/kg, Rompun, Bayern, Leverkusen, Germany) with 4% paraformaldehyde in 0.12 M phosphate buffer, pH 7.2 to 7.4. The brains were dissected and cut into 50 μm thick cryostat coronal sections. Sections were incubated and counterstained with 4′, 6-diamidino-2- phenylindole (DAPI). After processing, sections were mounted on microscope slides with Tris-glycerol supplemented with 10% Mowiol (Calbiochem). Quantitative and phenotypic evaluations were made on the images acquired with a Leica TCS SP5 confocal microscope. Fiji (http://fiji.sc/Image_Stitching), Inkscape (http://inkscape.org), and Photoshop CS6 (Adobe Inc. https://www.adobe.com) were used to assemble all figures.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
All data supporting the findings of this study are available within the paper and its Supplementary Information files. The source data behind the graphs can be found in Supplementary Data 1.
Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology. 23, 1231–1251 (2021).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Phillips, H. S. et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157–173 (2006).
CAS  PubMed  Article  Google Scholar 
Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98–110 (2010).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Dunn, G. P. et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 26, 756–784 (2012).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017).
CAS  PubMed  Article  Google Scholar 
Chen, X., Liao, R., Li, D. & Sun, J. Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications. Oncotarget 8, 17301–17312 (2017).
PubMed  Article  Google Scholar 
Fedele, M., Cerchia, L., Pegoraro, S., Sgarra, R. & Manfioletti, G. Proneural-mesenchymal transition: phenotypic plasticity to acquire multitherapy resistance in glioblastoma. IJMS 20, 2746 (2019).
CAS  PubMed Central  Article  Google Scholar 
Behnan, J., Finocchiaro, G. & Hanna, G. The landscape of the mesenchymal signature in brain tumours. Brain 142, 847–866 (2019).
PubMed  PubMed Central  Article  Google Scholar 
Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004).
CAS  PubMed  Article  Google Scholar 
Carro, M. S. et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318–325 (2010).
CAS  PubMed  Article  Google Scholar 
Mao, P. et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc. Natl Acad. Sci. USA 110, 8644–8649 (2013).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).
CAS  PubMed  Article  Google Scholar 
Perry, J. R. et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N. Engl. J. Med. 376, 1027–1037 (2017).
CAS  PubMed  Article  Google Scholar 
Zhang, W. et al. ALDH1A3: a marker of mesenchymal phenotype in gliomas associated with cell invasion. PLoS ONE 10, e0142856 (2015).
PubMed  PubMed Central  Article  CAS  Google Scholar 
Ferraris, D. M., Gelardi, E. L. M., Garavaglia, S., Miggiano, R. & Rizzi, M. Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer. Biochem. Soc. Trans. 48, 693–707 (2020).
CAS  PubMed  Article  Google Scholar 
Koppaka, V. et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharm. Rev. 64, 520–539 (2012).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Marchitti, S. A., Brocker, C., Stagos, D. & Vasiliou, V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin. Drug Metab. Toxicol. 4, 697–720 (2008).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Moretti, A. et al. Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD+ and retinoic acid. Sci. Rep. 6, 35710 (2016).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Duan, J.-J., Cai, J., Guo, Y.-F., Bian, X.-W. & Yu, S.-C. ALDH1A3, a metabolic target for cancer diagnosis and therapy. Int. J. Cancer 139, 965–975 (2016).
CAS  PubMed  Article  Google Scholar 
Tomita, H., Tanaka, K., Tanaka, T. & Hara, A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget 7, 11018–11032 (2016).
PubMed  PubMed Central  Article  Google Scholar 
Nwani, N. et al. A novel ALDH1A1 inhibitor targets cells with stem cell characteristics in ovarian cancer. Cancers 11, 502 (2019).
CAS  PubMed Central  Article  Google Scholar 
Kharkar, P. S. Cancer stem cell (CSC) inhibitors in oncology—a promise for a better therapeutic outcome: state of the art and future perspectives. J. Med. Chem. 63, 15279–15307 (2020).
CAS  PubMed  Article  Google Scholar 
Gelardi, E. L. M. et al. A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro. Cancers 13, 356 (2021).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Cheng, P. et al. FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res. 76, 7219–7230 (2016).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Li, J. et al. A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells. Commun. Biol. 4, 1–16 (2021).
Article  CAS  Google Scholar 
Clark, D. W. & Palle, K. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets. Ann. Transl. Med. 4, 518 (2016).
PubMed  PubMed Central  Article  CAS  Google Scholar 
Januchowski, R., Wojtowicz, K. & Zabel, M. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Biomed. Pharmacother. 67, 669–680 (2013).
CAS  PubMed  Article  Google Scholar 
Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714–726 (2013).
CAS  PubMed  Article  Google Scholar 
Januchowski, R. et al. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines. Int. J. Biochem. Cell Biol. 78, 248–259 (2016).
CAS  PubMed  Article  Google Scholar 
Quattrini, L. et al. Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells. J. Med. Chem. 63, 4603–4616 (2020).
CAS  PubMed  Article  Google Scholar 
Quattrini, L. et al. Progress in the field of aldehyde dehydrogenase inhibitors: novel Imidazo[1,2-a]pyridines against the 1A family. ACS Med. Chem. Lett. 11, 963–970 (2020).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Shahcheraghi, S. H. et al. Therapeutic potential of curcumin in the treatment of glioblastoma multiforme. Curr. Pharm. Des. 25, 333–342 (2019).
CAS  PubMed  Article  Google Scholar 
Purkayastha, S. et al. Curcumin blocks brain tumor formation. Brain Res. 1266, 130–138 (2009).
CAS  PubMed  Article  Google Scholar 
Gersey, Z. C. et al. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer 17, 99 (2017).
PubMed  PubMed Central  Article  CAS  Google Scholar 
Nelson, K. M. et al. The essential medicinal chemistry of curcumin: miniperspective. J. Med. Chem. 60, 1620–1637 (2017).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Park, K.-S. et al. A curcumin-based molecular probe for near-infrared fluorescence imaging of tau fibrils in Alzheimer’s disease. Org. Biomol. Chem. 13, 11194–11199 (2015).
CAS  PubMed  Article  Google Scholar 
Wang, X. et al. Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells. Int. J. Oncol. 51, 467–477 (2017).
CAS  PubMed  PubMed Central  Article  Google Scholar 
Kamada, K. et al. Boron difluoride curcuminoid fluorophores with enhanced two-photon excited fluorescence emission and versatile living-cell imaging properties. Chem. Eur. J. 22, 5219–5232 (2016).
CAS  PubMed  Article  Google Scholar 
Hishii, M., Matsumoto, T. & Arai, H. Diagnosis and treatment of early-stage glioblastoma. Asian J. Neurosurg. 14, 589–592 (2019).
PubMed  PubMed Central  Article  Google Scholar 
Caprioglio, D. et al. Triazole-curcuminoids: a new class of derivatives for ‘tuning’ curcumin bioactivities? Bioorg. Medicinal Chem. 24, 140–152 (2016).
CAS  Article  Google Scholar 
Koeberle, A. et al. SAR studies on curcumin’s pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase. J. Med. Chem. 57, 5638–5648 (2014).
CAS  PubMed  Article  Google Scholar 
Caldarelli, A., Penucchini, E., Caprioglio, D., Genazzani, A. A. & Minassi, A. Synthesis and tubulin-binding properties of non-symmetrical click C5-curcuminoids. Bioorg. Med. Chem. 21, 5510–5517 (2013).
CAS  PubMed  Article  Google Scholar 
Minassi, A., Sánchez-Duffhues, G., Collado, J. A., Muñoz, E. & Appendino, G. Dissecting the pharmacophore of curcumin. Which structural element is critical for which action? J. Nat. Prod. 76, 1105–1112 (2013).
CAS  PubMed  Article  Google Scholar 
Pabon, H. J. J. A synthesis of curcumin and related compounds. Recl. Trav. Chim. Pays-Bas 83, 379–386 (1964).
CAS  Article  Google Scholar 
Cai, L., Innis, R. B. & Pike, V. W. Radioligand development for PET imaging of beta-amyloid (Abeta)–current status. Curr. Med. Chem. 14, 19–52 (2007).
CAS  PubMed  Article  Google Scholar 
Agalave, S. G., Maujan, S. R. & Pore, V. S. Click chemistry: 1,2,3-triazoles as pharmacophores. Chem. Asian J. 6, 2696–2718 (2011).
CAS  PubMed  Article  Google Scholar 
Anand, P., Kunnumakkara, A. B., Newman, R. A. & Aggarwal, B. B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4, 807–818 (2007).
CAS  PubMed  Article  Google Scholar 
Van Nong, H. et al. Fabrication and vibration characterization of curcumin extracted from turmeric (Curcuma longa) rhizomes of the northern Vietnam. SpringerPlus 5, 1147 (2016).
PubMed  PubMed Central  Article  CAS  Google Scholar 
Morgan, C. A., Parajuli, B., Buchman, C. D., Dria, K. & Hurley, T. D. N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes. Chem. Biol. Interact. 234, 18–28 (2015).
CAS  PubMed  Article  Google Scholar 
Díez Valle, R., Hadjipanayis, C. G. & Stummer, W. Established and emerging uses of 5-ALA in the brain: an overview. J. Neurooncol. 141, 487–494 (2019).
PubMed  Article  CAS  Google Scholar 
Neira, J. A. et al. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. J. Neurosurg. 127, 111–122 (2017).
PubMed  Article  Google Scholar 
Katsevman, G. A., Turner, R. C., Urhie, O., Voelker, J. L. & Bhatia, S. Utility of sodium fluorescein for achieving resection targets in glioblastoma: increased gross- or near-total resections and prolonged survival. J. Neurosurg. 132, 914–920 (2019).
PubMed  Article  Google Scholar 
SigmaPlot Extract Graphs and Data Analysis (StatSys v12.3)SigmaPlot (RRID:SCR_003210). URL: http://www.sigmaplot.com/products/sigmaplot/.
Xie, Y. et al. The human glioblastoma cell culture resource: validated cell models representing all molecular subtypes. EBioMedicine 2, 1351–1363 (2015).
PubMed  PubMed Central  Article  Google Scholar 
Azzalin, A. et al. A new pathway promotes adaptation of human glioblastoma cells to glucose starvation. Cells 9, 1249 (2020).
CAS  PubMed Central  Article  Google Scholar 
Szatmari, T. et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci. 97, 546–553 (2006).
CAS  PubMed  Article  Google Scholar 
Download references
S.G., A.M. and D.M.F. acknowledge the University of Piemonte Orientale (grant Ricerca Ateneo FAR_2016 and FAR_2019) and ROCHE per la Ricerca 2017, for the financial support. L.M. was supported by Fondazione I.R.C.C.S. Policlinico S. Matteo Ricerca Corrente (codice ric. 08016019). S.G. and A.M. acknowledge Professor Fabrizio Condorelli for the stimulating scientific discussion regarding this paper. We acknowledge the HIS Mouse Facility of the Academic Medical Center, Amsterdam and the Bloemenhove Clinic (Heemstede, The Netherlands) for providing fetal tissues. We would also thank Dott. Alberto Azzalin for his help with rMarkII flow cytometer. We acknowledge “HGCC” Uppsala University, Department of Immunology, Genetics and Pathology and its unit HGCC, (Rudbecklaboratoriet, 751 85 Uppsala, Sweden) for providing Patient-derived glioblastoma cells.
These authors contributed equally: Edoardo L. M. Gelardi, Diego Caprioglio.
Dipartimento di Scienze del Farmaco, University of Piemonte Orientale, Via Bovio, 6, 28100, Novara, Italy
Edoardo L. M. Gelardi, Diego Caprioglio, Giorgia Colombo, Erika Del Grosso, Daniele Mazzoletti, Daiana Mattoteia, Stefano Salamone, Davide M. Ferraris, Menico Rizzi, Alberto Minassi & Silvia Garavaglia
IXTAL srl, Via Bovio 6, 28100, Novara, Italy
Davide M. Ferraris
Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Eleonora Aronica
Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands
Eleonora Aronica
Department of Life Sciences and System Biology, University of Turin, Via Accademia Albertina 13, Turin, Italy
Giulia Nato & Annalisa Buffo
Neuroscience Institute Cavalieri Ottolenghi (NICO), 10043, Orbassano, TO, Italy
Giulia Nato
Department of Neuroscience Rita Levi Montalcini, University of Turin, Via Cherasco 15, Turin, Italy
Annalisa Buffo
Neurosurgery, Department of Clinical, Surgical, Diagnostic and Pediatric Science, University of Pavia, Foundation IRCCS Policlinico San Matteo, 27100, Pavia, Italy
Lorenzo Magrassi
Istituto Di Genetica Molecolare IGM-CNR, Via Abbiategrasso 207, 27100, Pavia, Italy
Lorenzo Magrassi
PlantaChem srls, Via Canobio 4/6, 28100, Novara, Italy
Alberto Minassi
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
E.L.M.G., D.C. and G.C. designed and performed all the experiments and wrote the manuscript. D.C., D. Matt. and S.S. synthesized the fluorescent probe. E.L.M.G. and D. Mazz. purified the recombinant enzymes and performed all the biochemical evaluation experiments. G.C. and L.M. performed all the experiment with the cancers cell lines and the flow cytometric studies. E.D.G. performed all the LC-HRMS experiments. E.A. contributed expertise and the human fetal astrocytes. G.N., A.B. and L.M. performed the in vivo experiments. D.M.F., L.M. and M.R. provided funding, contributed expertise and revised the final version of the manuscript. A.M. and S.G. provided funding, supervised and supervised all the experiment, wrote the manuscript.
Correspondence to Alberto Minassi or Silvia Garavaglia.
The authors declare the following competing interest: the work reported in these papers led to a patent name: “PROBE DIRECTED TO ENZYME ALDH1A3 AND USE THEREOF IN THE DIAGNOSIS OF GLIOBLASTOMA”; number: PCT/IB2022/053216 (6 April 2022); geographical region: International Application (PCT); applicants: University of Piemonte Orientale 90%; University of Pavia 10%; inventors: S.G., A.M., M.R., E.L.M.G., D.C., G.C., L.M.
Communications Biology thanks Deju Ye and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Christina Karlsson Rosenthal.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Reprints and Permissions
Gelardi, E.L.M., Caprioglio, D., Colombo, G. et al. Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis. Commun Biol 5, 895 (2022). https://doi.org/10.1038/s42003-022-03834-7
Download citation
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s42003-022-03834-7
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
Advertisement
Advanced search
Communications Biology (Commun Biol) ISSN 2399-3642 (online)
© 2022 Springer Nature Limited
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

source

Blancpain, Biopixel & the Battle to Save the Great Barrier Reef – Man of Many

Share this on
Send this by
The author of this article, Rob Edwards, was invited to visit the Great Barrier Reef as a guest of Blancpain.
Share this on
Send this by
When swimming in deep water, there are any number of things you don’t want to experience, but somewhere near the top of the list must surely be a sudden, unshakable sense that you’re being watched. During a recent visit to the Great Barrier Reef with Blancpain, a marine researcher described this sensation to me as “feeling sharkie” and insisted it’s something you ignore at your peril.
You’ll also love:
Hands On with the Remarkable New Blancpain Air Command Watch
Blancpain Pays Tribute to the Past with Fifty Fathoms No Rad Limited-Edition Timepiece
Blancpain’s Fifty Fathoms Scores Titanium Upgrade

Blanpain biopixel 6

A fish named “Wally” | Image: Christian Miller

A fish named “Wally” | Image: Christian Miller
A few hours after that particular exchange, I found myself floating about 50 metres from the boat that had been puttering us around to various dive spots throughout the day. Looking down into the inky depths, I suddenly felt the “sharkie” sensation shoot through my veins like ice. While trying my very best to appear unflustered on the surface, I kicked my way back to the boat and was out of the water in a flash. Later that evening, I described the feeling to another reef expert, before reassuring myself out loud that it was all in my head. His response: “There’s no guarantee.”
He was all too right. In fact, it seems there’s very little that’s guaranteed when it comes to the Great Barrier Reef, including its chances of remaining “great” for much longer without dedicated action to ensure its longevity. Much to the surprise of myself and the other guests present for our aquatic jaunt, Blancpain didn’t invite us along in order to reveal a fancy new dive watch – despite being the brand that developed the world’s first modern dive watch and has a CEO known for his diving enthusiasm – but rather to press upon us the importance of reef restoration and preservation. This is a cause Blancpain is helping to drive through a partnership with a charmingly ragtag but absolutely devoted and highly skilled outfit called Biopixel, which operates alongside a handful of affiliate organisations and volunteers.

Blanpain biopixel 2

Richard Fitzpatrick in his element | Image: Christian Miller

An Emmy Called “That Old Thing”

Richard Fitzpatrick in his element | Image: Christian Miller
To put it simply, Biopixel is the Emmy Award-winning team of marine biologists and underwater cinematographers that David Attenborough hits up when he needs some slick footage of the Great Barrier Reef for his next documentary. But not only does Biopixel immortalise the natural beauty of the underwater world for us to enjoy from the comfort of our living rooms, the team’s heavily involved in a range of projects designed to protect and restore the Reef for generations to come.
Operating out of James Cook University, Biopixel is led by Richard Fitzpatrick, a man who’s had more one-on-one time with large, carnivorous marine life than any sane person should admit – and yes, Fitzpatrick refers to the team’s Emmy as “That old thing.” He established the underwater photography side of Biopixel in 2013 alongside Bevan Slattery and a few years later the pair expanded into conservation with the Biopixel Oceans Foundation, which is dedicated to research, exploration and education.
During our brief but inspiring time with this team of remarkable individuals, we saw a number of projects that gave us hope for the future of the Great Barrier Reef and the mission to protect and restore underwater life more broadly.

Blanpain biopixel 3

Image: Christian Miller

The Professor & His Fish

Image: Christian Miller
First, we met Professor Jamie Seymour of James Cook University. He’s the director of the Tropical Australian Venom Research Unit and a man whose enthusiasm for odd and deadly sea life is infectious, from the tiny but incredibly dangerous jellyfish he keeps in a tank to the venomous stonefish he’ll casually cradle in his hands. With his team, Seymour explores the potentially enormous medicinal value of these creatures, whether by using box jellyfish venom to overcome pancreatic cancer or taking the fight to bacteria that’s resistant to antibiotics.
Seymour’s also known for his collaboration with Fitzpatrick on Biopixel’s Aquarium Studio, one of the largest dedicated marine filming facilities in the world. Here, the Biopixel team is able to capture aquatic events that would be impossible to film in the wild. So the next time you hear Attenborough narrate that a scene “has never before been captured on film”, it could well have been shot using controlled conditions under Seymour’s supervision.
Sitting alongside some of the filming pools, Seymour’s research facility also boasts an offshoot of the Cairns Turtle Rehabilitation Centre – more on that a little later – with the filming facility surrounded by tanks that contain a number of turtles at various stages of their journey towards being returned to the wild. As an aside, it was here that attendees discovered turtles actually like to have their shells scratched, much like a puppy would its back. They’ll splash their fins in approval and swim back around for another scratch.

Blancpain biopixel 7

Image: Christian Miller

Reef Restoration

Image: Christian Miller
When it comes to actually protecting the Great Barrier Reef more directly, there are a number of ways in which the Biopixel team and its affiliates are making a tangible difference. The first is through the Mars Assisted Reef Restoration System (MARRS). Yes, that’s Mars as in the chocolate company, which has recognised that 90 per cent of the world’s coral reefs could be gone by 2050, having a devastating effect on biodiversity and populations worldwide.
In order to address this, the team developed a process that’s been successfully deployed both here in Australia and for numerous other reefs worldwide. This process includes fixing a number of hexagonal metal structures (known as Reef Stars) into parts of reef that have been bleached beyond repair. These Reef Stars – 348 of which have now been deployed – are coated with resin and coral sand, which are designed to encourage corals and other animals to settle, helping to rebuild the Reef.

Marrs reef stars

MARRS Reef Stars | Image: Mars

MARRS Reef Stars | Image: Mars
I saw the extraordinary results of this program for myself. Visiting four different locations that had received the MARRS treatment over the last 18 months, the effectiveness of the strategy was clear. While the newest installation looked like little more than a collection of metal frames, as we visited each new location the progress was clear. When we finally arrived at the oldest installation, it just looked more or less like a healthy, functioning reef. It was truly impressive.
Another system being deployed to help the Great Barrier Reef return to its full glory is the deployment of robots designed to either eliminate destructive Crown-Of-Thorns Starfish (COTS) or disperse larvae to help the Reef regrow. Operated out of the Queensland University of Technology (QUT) and overseen by robotics expert Professor Matthew Dunbabin, these drones are having a dramatic impact on the health of the Reef.

Blanpain biopixel 4

A “LarvaBot” in action | Image: Christian Miller

A “LarvaBot” in action | Image: Christian Miller
The program uses two different but equally important robots. The first is the “COTSbot” (Crown-Of-Thorns Starfish robot), which helps to control the starfish population by delivering lethal injections to individual organisms before human divers sweep in to remove any survivors. The second, “LarvaBots”, took over the responsibility for larva dispersal from human divers and have proved themselves capable of deploying more than 10 times the amount of coral larvae into depleted areas of the Reef than their fleshy predecessors.
The program has been extremely successful, with Dunbabin informing us it has seen a 100 per cent success rate in delivering coral larvae to damaged reefs and 99.4 per cent accuracy in detecting COTS.

Heroes of the Half-Shelled

Finally, we can return to the aforementioned Cairns Turtle Rehabilitation Centre. On our last day with the Biopixel team, we were treated to a guided tour of an impressive not-for-profit facility operating behind the curtain at the Cairns Aquarium. Here, sea turtles of the Green, Loggerhead and Hawksbill varieties – to name but a few – are cared for until they’re ready to dive back into the big blue.
From boat collisions to limb damage, infectious diseases to the trauma that comes with net entanglement, many of the turtles we saw had been dealt a bad hand, but the dedicated team led by Jennie Gilbert does great work treating their shelled patients, with over 170 having been helped by the organisation.

Blancpain biopixel 8

Image: Christian Miller

There’s a Big Ocean Out There

Image: Christian Miller
The efforts of Biopixel and its affiliates go far beyond even the ambitious projects I’ve outlined here. I haven’t touched on the Megamouth project, which tracks whale sharks and manta rays, or the Raine Island project, which sees the team attempting to address turtle reproductive challenges.
The scale and breadth of Biopixel’s efforts are truly remarkable and I’m grateful the team is out there doing all it can, with the support of Blancpain, to ensure that the Great Barrier Reef and the awe-inspiring creatures that inhabit it are in with a shot of enduring for the centuries to come. Even if that means future generations must in turn endure the sensation that comes with that “sharkie” feeling.
Check it out
Related: Discover more about the Blancpain watch I was able to wear while diving.

Blancpain biopixel 9

“Wally” returns | Image: Christian Miller

AUTHOR

Rob Edwards

Rob Edwards is Man of Many’s Branded Content Writer. As a former editor of Australian T3 and Official Nintendo Magazine Australia, he has a wealth of experience covering the very latest in consumer technology, gaming, and lifestyle products. While Rob likes to think of himself as a reformed musician – he spent years gigging around Australia’s dingiest venues – his addiction to guitars goes on unabated, as he remains eternally convinced that surely the next guitar he buys will be the one to make him feel whole.

“Wally” returns | Image: Christian Miller
Share this on
Send this by
Rob Edwards is Man of Many’s Branded Content Writer. As a former editor of Australian T3 and Official Nintendo Magazine Australia, he has a wealth of experience covering the very latest in consumer technology, gaming, and lifestyle products. While Rob likes to think of himself as a reformed musician – he spent years gigging around Australia’s dingiest venues – his addiction to guitars goes on unabated, as he remains eternally convinced that surely the next guitar he buys will be the one to make him feel whole.
Man of Many provides content of a general nature that is designed for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment or for professional financial advice. Click here for additional information.

source

Bubba Brothers Release Newest Title, 'Basstribe EP' – EDM Sauce

Hi, what are you looking for?
Police Stop Possible Mass Shooting Threat At Bass Canyon
EDMsauce.com Artist of the Week: Pixellay
DISCO FRIES Unveils ‘Friends of Fries’ NFT PACK with RCRDSHP
Griffter rings in the weekend with gritty bass track “All Out” ft. Jones 2.0
AJ Salvatore Crosses Into Rap with “Vitamins” ft. Tokyo’s Revenge
8OhAce Gives Us Some Nostalgia With Skrillex Classic Remix
Hotboxx Strikes Gold with Newest Record, ‘Hialeah’
subduxtion Just Dropped a Super Powerful Record Titled, ‘Rezone’
Bubba Brothers Release Newest Title, ‘Basstribe EP’
VARGAS Gives Us Rock Inspired, Orchestral Remix of Kloud’s YN










By
Published
Fantastic DJ and music production duo Bubba Brothers are back with a new impressive release, a 2-track remarkable EP ‘Basstribe’ comes out via the duo’s own label Mossdeb Sounds.

The duo consisting of Eliseu Correia and Justino Santos, have more than 5 years of experience behind the mixing decks; during this time, their project has taken them far, performing at the most iconic venues and festivals around the world, like Dancefloor Leiria in Portugal, Ministry of Sound in London, and recently Es Paradis in Ibiza. Bubba Brothers have certainly become one of the most popular and sought-after acts in the Dance music world, with their releases being proof of this, their tracks have been featured on influential charts like the Beatport Top 100. The duo is here with a new production that will surely surpass their previous success.
The opening track ‘Bass’ starts the party with a pounding beat with playful small percussive elements that get the listener into the overall magnetic vibe. A bouncy and well-rounded mighty bass and panned sounds keep the track dynamic and energetic. Talking voice samples take space in the middle of the mix. This track surely brings a powerful vibe to the dance floors everywhere. Synth stabs appear in the middle of the track and make this song reach a new level.

Next up is ‘Tribe’ with conga lively percussive beat, powerful basslines, and playful vocal chops; smaller sonic elements play around in the mix, as the track makes its way to constant drops that add a new layer of sound every time. The powerful lower-end maintains the party going and towards the end of the track, a layer of pads and synths take the spotlight, adding a new melody to which the beat can wrap around to take the party feel to new heights.
Lovers of House music and a great listening and dancing journey, will find this EP a new instant favorite as the tracks evolve and transform themselves to powerful and energizing experiences for everybody who’d listen.
Bubba Brothers are surely on a mission to conquer the Dance music world, one release at a time. Make sure to follow them as they continue to put out impressive productions.
‘Basstribe’ is out now and available in all major online stores and streaming platforms.

Advertisement. Scroll to continue reading.

Listen and buy ‘Basstribe’ now
https://soundcloud.com/bubbabrothersofficial/bubba-brothers-bass-new-master
https://soundcloud.com/bubbabrothersofficial/bubba-brothers-tribe
https://www.beatport.com/release/basstribe-ep/3831001
Bubba Brothers Online
Spotify | Soundcloud | Instagram
Mossdeb Sounds Online
Beatport | Instagram
 

Advertisement. Scroll to continue reading.

Floormagnet started their musical journey to get where they are today over 30 years ago, sparked by a fascination for the genre that started with…
Dutch breakout artist UNIKID returns to esteemed tastemaker label Frequency Music with his debut EP In Times Past. Out now on all platforms, In Times Past showcases UNIKID’s…
After debuting three enticing lead singles “Revelation,” “High On You,” and “La Pasion,” Matroda finally unveils his Jack The House 2 EP in full. Out now…

What is going on dance music nation? We are so happy to bring you only the BEST in up and coming music, and today…




Copyright © EDM Sauce

EDM Sauce is reader-supported. We may earn a commission through products purchased using links on this page. Learn more about our process here.

source

South Carolina Gamecocks football live mascot back to 'Sir Big Spur' name – ESPN

COLUMBIA, S.C. — Upon further review, South Carolina’s live, crowing mascot will go back to his old name, “Sir Big Spur.”
The school announced the rooster’s status Thursday, just three days after choosing “The General” as a new name due to a dispute between the old and new owners.
But after feedback the athletic department received about the new name, there was more dialogue between old owners Mary Snelling and Ron Albertelli, and new owners Beth and Van Clark. Snelling and Albertelli had the rights to the name “Sir Big Spur” and would not at first agree to keep that for this season.
In a statement, the school said the two families and South Carolina administrators talked and found a solution in the best interest of the university while respecting the wishes of both families.
South Carolina deputy athletic director Eric Nichols said keeping the old name was always first choice. “We are pleased we are starting the season with the same name as in years past,” he said.
“Sir Big Spur” will be on the sidelines Saturday night as South Carolina hosts Georgia State to start the season.

source

Will Eisner Graphic Novel ‘A Contract With God’ Set For Stage Musical Adaptation – Deadline

By Greg Evans
Associate Editor/Broadway Critic
Will Eisner’s groundbreaking 1978 graphic novel A Contract With God is being developed into a stage musical featuring music by Sam Hollander, Lisa Loeb, Matisyahu, Ryan Miller and Jill Sobule.
TEG+, the recently launched venture of Broadway producer Vivek J. Tiwary, has acquired the stage rights, and Hollander, who has composed songs for Panic! At The Disco, One Direction and Katy Perry, will serve as music producer.
TEG+ is currently in the process of securing a book writer for the musical adaptation.
First published in 1978, A Contract With God is considered a pioneering effort in the history of graphic novels, and consists of four interweaving stories revolving chronicling the lives of various New Yorkers — many Jewish and many immigrants — living in a fictional tenement house.

James Earl Jones Theatre Gets Official Broadway Opening: Renaming & Dedication Ceremony Announced

In announcing the project today, TEG+ said “All of the members of the songwriting team are Jewish musicians and composers wishing to honor their Jewish heritage and the Jewish legacy of this masterwork. The team is about to enter writing and recording sessions, produced by Hollander.”
“When Vivek sent me Will Eisner’s A Contract With God, I was instantly floored,” said Hollander in a statement. “Getting the chance to bring this seminal graphic novel to the stage in collaboration with an iconic crew of my talented Jewish pals is just the greatest thrill ever. It’s an amazing way for us all to honor our heritage while bringing this story of the 1930s New York immigrant struggle to a new audience.”
Added Tiwary, “For me, A Contract With God was a formative ground zero for all my creative work. I never met Will Eisner, and still he is one of the great mentors of my life. Like Will, I was born in New York City, a child of immigrants who grew up surrounded by immigrant dreams, both beautiful and frustrating. A Contract with God helped me understand both New York City and myself. I’m thrilled to now work alongside this group of top-notch inspiring Jewish musicians to bring a stage production of A Contract with God to both fans of the graphic novel and to inspire new audiences.”
The new project is the latest Broadway venture from TEG+, joining the recently announced adaptation of classic children’s book Harold and the Purple Crayon with original songs by the band AJR. In addition to upcoming Broadway projects, TEG+ previously announced the acquisition of film and TV rights to adapt the story of The Lazy Susans, an unlikely rock band of suburban moms.

TEG+ is also in development for a limited TV series The Fifth Beatle: The Brian Epstein Story. The Fifth Beatle is the only project about Brian Epstein, and the only non-documentary Beatles bio project, to have secured their music/songs.
A Contract With God, Harold and the Purple Crayon, The Lazy Susans adaptation and The Fifth Beatle are part of a TEG+ slate of 10 new projects revolving around high profile music, the rest of which will be announced in the coming months.
Subscribe to Deadline Breaking News Alerts and keep your inbox happy.
Signup for Breaking News Alerts & Newsletters
Get our latest storiesin the feed of your favorite networks
We want to hear from you! Send us a tip using our annonymous form.
Sign up for our breaking news alerts
Deadline is a part of Penske Media Corporation. © 2022 Deadline Hollywood, LLC. All Rights Reserved.

source

Opera Southwest celebrating 50 years – Albuquerque Journal

Albuquerque Journal
New Mexico and ABQ News, Sports, Business and more



bright spotOpera Southwest is nothing if not a survivor.
Now celebrating its 50th anniversary, the company has endured catastrophic fires, near-bankruptcies and cancellations.
“It survived all these years because there is an appetite for opera in Albuquerque,” executive director Anthony Zancanella said.
The company will celebrate with a Zorro-themed Oct. 1 gala at Hotel Albuquerque.
OSW has presented many world premieres of new operas in addition to the standard repertoire. In 2015, its production of Franco Faccio’s “Amleto (Hamlet),” the opera’s first performance in 143 years, was a finalist in the International Opera Awards.
In 1972, University of New Mexico music professor/conductor Kurt Frederick and Dr. Edward T. Peter launched what was then called the Albuquerque Opera Theatre.
“It’s not clear if anyone thought it would take off,” Zancanella said, adding that funding was “almost none.”
Frederick was an Austrian-born violinist who fled the Nazis in 1942 and landed in Albuquerque. Peter was chief of surgery at the University of New Mexico Hospital who performed the first kidney transplant in the state. Opera was his hobby, Zancanella said.
Peter took the job of stage director; Frederick was the conductor and general taskmaster.
Their first performance was the Mozart classic “Così fan tutte” in UNM’s Popejoy Hall in 1973. The 1974-75 season featured Strauss’ “Die Fledermaus” and Giacomo Puccini’s “La Bohème.”
Your email is safe with us, we don’t spam
“They were intrepid fundraisers,” Zancanella said of the founders. “These people were really passionate about the art form.”
Soprano Donna McRae sang the role of Fiordiligi in the maiden production.
“Of course, the singers didn’t get paid,” she said.
Frederick demanded perfection, she added.
“He was excellent and he expected quality work,” she said. “It was a good audience. I think Albuquerque was very hungry for opera at that point. I just remember a very good feeling about it.”
Justine (Sally) Opel wore “at least a dozen” hats at the opera, culminating in her work as production manager and stage director after she joined the company in 1977.
“I did all the jobs, but I didn’t do it alone,” she said.
Opel had studied theater at Yale University before her career propelled her to Broadway. She was originally hired as an administrator at OSW, a job entailing budgets, check writing, scheduling and tax statements.
“They got me to direct the first ‘Traviata,’ ” she said.
Money was an ever-present concern.
“We had a couple of moments when one of the board members stole money,” she said. “We owed a lot of money.”
During the 18th season, the company switched to piano accompaniment in lieu of hiring a full orchestra.
“We owed $225,000,” Opel said. “We built every set and we maintained every costume or made some. We all worked together. We were blessed with people who forgave our debt.”
Local orthodontist Arthur Hawkins took on the company’s old loans, which they paid back across 10 years, Opel said.
“These were people who knocked themselves out with generosity,” she added. “We all wanted to do opera and we had an audience. We had no problem we couldn’t solve.”
At one point, Opel earned $300 per month, then her salary got cut.
“I was paid back some of it,” she said. “We staged over 65 operas.”
And then there were the glitches. When the company moved to the KiMo Theatre in the 1980s, PNM had just installed the lights.
“We opened the KiMo with ‘Hansel and Gretel,’ ” Opel said. “At the beginning of the second act, we had a blackout.
“We played the rest of the opera with the strip lights that sit on the stage. We lived the rest of that opera in a blue wash.”
A fire scorched the OSW warehouse in 1990, destroying costumes, sets and props.
“Nobody quit,” Zancanella said. “They had to start all over again. They had one or two brushes with bankruptcies.
“They struggled for finances,” McRae said. “There was one role I had to learn twice. They had to cancel it because of lack of funds.”
That opera was Mozart’s “The Marriage of Figaro.”
“It struggled for years and then they finally got a really good board,” she said.
By the 1980s, organizers were staging three operas annually. Now they schedule four per year.
OSW began with a budget of about $500,000, Zancanella said. Today, it tops $1.2 million. The classical radio station WFMT in Chicago produces its live broadcasts. Critics have come from as far away as Milan, Italy, London and Germany.
“We do world-class opera on an Albuquerque budget,” Zancanella said.
Zancanella and music director/conductor Anthony Barrese arrived 10 years ago with a commitment to lost and forgotten works, operas by Hispanic composers and Gioachino Rossini, Barrese’s favorite operatic composer, as well as one fully-staged classic.
“We’ve done more Rossini than anybody in the country, including the Metropolitan Opera,” Zancanella said.
This year’s classic is Puccini’s “Turandot” on March 12, 15, 17 and 19, 2023. “Zorro” by Héctor Armienta (He also created the 2018 operatic production of “Bless Me, Ultima”) is on Oct. 23, 26, 28 and 30. Rossini’s “Le comte Orly” is scheduled for Feb. 5, 10 and 12, 2023. All are at the National Hispanic Cultural Center.
The opening opera, “Le Loup-garou” by Louise Bertin, will take place at the Albuquerque Museum Amphitheater on Sept. 9, 10 and 11.
OSW enjoys a cordial relationship with the Santa Fe Opera, regularly renting costumes and props from the summer festival. The SFO also offers summer jobs to OSW workers.
Zancanella hopes to raise $2.5 million in current fundraising and dreams of an outdoor summer festival.
To date OSW has produced more than 140 major operas for hundreds of thousands of patrons. Organizers have mounted 23 world premieres.
Opera Southwest 50th Anniversary Gala
WHEN: 6 p.m. Oct. 1
WHERE: Hotel Albuquerque, 800 Rio Grande Blvd.
HOW MUCH: $250 per person at operasouthwest.org/gala

More Arts


Sharing

source

2 Central NY teens dead after contacting live wires after truck crashes into downed tree – syracuse.com

Redfield, N.Y. — Two teens are dead after they came in contact with live wires after a truck crashed into a downed tree in Oswego County Wednesday night, deputies said.
Dead are Madysen Young, 17, of Sandy Creek and Matthew Bice, 17, of Albion, deputies said.
Young was driving a 2008 Chevrolet pickup truck at 10:47 p.m. on County Route 17 in Redfield when the truck hit a tree that had been brought down by a storm, according to a news release from the Oswego County Sheriff’s Office.
The truck ended up in a ditch.
No one was injured in the crash itself, said Lt. Andy Bucher, a spokesperson for the Oswego County Sheriff’s Office.
Young and Bice got out of the truck and came into contact with the live wires that had been pulled down by the tree, deputies said.
The girl and boy were pronounced dead at the scene, deputies said.
Two 16-year-old boys who were in the truck were uninjured, deputies said.
The crash happend in the area of of 6200 County Route 17, a two-lane rural road.
Bice graduated from the Pulaski school district this year, according to a notice to parents put out by the district. Young was entering her senior year at Sandy Creek High School, the notice said.
Staff writer Rylee Kirk covers breaking news, crime and public safety. Have a tip, story idea, photo, question or comment? Reach her at 315-396-5961, on Twitter @kirk_rylee, or [email protected].
Note to readers: if you purchase something through one of our affiliate links we may earn a commission.
Registration on or use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your California Privacy Rights (User Agreement updated 1/1/21. Privacy Policy and Cookie Statement updated 7/1/2022).
Cookie Settings
© 2022 Advance Local Media LLC. All rights reserved (About Us).
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local.
Community Rules apply to all content you upload or otherwise submit to this site.
Ad ChoicesAd Choices

source

‹ Previous Next ›